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ABSTRACT
Plant  sterols  and  stanols  (collectively  named  as  phytosterols)  are  plant-derived
dietary compounds. The intake of natural phytosterols from a habitual Western diet
varies between 150 to 400 mg/d. Phytosterols are added to functional foods for their
serum cholesterol-lowering effect and their intake increases greatly when phytosterol
enriched  functional  foods  are  consumed.  Phytosterols  reduce  the  absorption  of
dietary and biliary cholesterol from the intestine, leading to increased concentrations
of  cholesterol  excreted  in  the  feces.  Increased  fecal  cholesterol  may  act  as  a
carcinogen in the intestinal lumen.
The  focus  of  this  thesis  was  to  study  the  effect  of  plant  sterols  and  stanols  on  the
tumor formation in the ApcMin mouse, an experimental model of colon cancer. The
ApcMin  carries  an  inherited  mutation  in  the Apc tumor-suppressor gene, which
eventually leads to the development of adenomas in the intestine. Mice were fed a
control  diet  or  a  0.8%  (w/w)  plant  sterol/  stanol  diet.  Commercial  foods  enriched
with  plant  sterols  or  stanols  were  used  to  compose  the  experimental  diets.  The
calculated  daily  intake  of  phytosterols  was  equivalent  to  5  g/d  for  a  man  when
adjusted for energy consumption. The impact of phytosterol feeding on cell signaling
pathways involved in intestinal tumorigenesis and the changes in sterol metabolism
were studied in the intestinal mucosa of ApcMin mouse. The final part of this work
assesses the intake of phytosterols from enrichment among Finnish men and women
from the FINDIET 2007 Survey.
Both plant sterols and plant stanols increased the number of adenomas in the small
intestine of ApcMin mice. Plant stanol feeding increased the number of intestinal
tumors in both genders, whereas plant sterol feeding increased the number of tumors
more pronouncedly in female mice. Wnt- β-catenin and Egfr signaling were up-
regulated in the intestinal mucosa of plant stanol fed ApcMin mice when compared
with control mice. Plant sterol and stanol feeding increased fecal cholesterol
7concentration that positively associated with the number of intestinal adenomas.
Significant changes in the composition of intestinal sterols were observed after plant
sterol and stanol feeding. It appears that plant sterol feeding affects genders
differently,  and  estrogen  signaling  may  play  a  role  in  intestinal  tumorigenesis  in
female ApcMin  mice  after  plant  sterol  feeding.  Overall,  the  mice  responded  in  a
different manner to plant sterol and plant stanol feeding in intestinal sterol handling,
cell signaling, and tumor development.
Finally,  this  thesis  shows that  according to the FINDIET 2007 Survey the intake of
phytosterols  from  enrichment  can  go  beyond  the  advised  intake;  for  20%  of  those
using phytosterol enriched products the intake of phytosterols was more than 3 g/d.
The consistency or duration of the consumption of phytosterol enriched products
was not determined in this work. The results show that phytosterols at high intakes
are harmful in the intestine of tumor-prone mice. Whether phytosterols from
enrichment affect human intestinal health warrants for further research.
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ABBREVIATIONS
ABCG5/8 ATP-binding cassette (ABC) transporters G5/8
ABCA1  ATP-binding cassette (ABC) transporter A1
ACAT acetyl-CoA:cholesterol acyltransferase
AKT protein kinase B
APC human adenomatous polyposis coli gene
Apc murine adenomatous polyposis coli gene
APC adenomatous polyposis coli protein
CHD coronary heart disease
CRC colorectal cancer
CYP27 sterol 27-hydroxylase
DMH 1,2-dimethylhydrazine
EGFR epidermal growth factor receptor
ER estrogen receptor
ERK extracellular signaling regulated kinase
FAP familial popyposis coli
GSK3β glycogen synthase kinase 3β
HDL high-density lipoprotein
HMGCR 3-hydroxy-3-methylglutaryl-CoA-reductase
LDL low-density lipoprotein
LDL-C LDL-cholesterol
LXR liver X receptor
MAPK mitogen-activated protein kinase
Min multiple intestinal neoplasia
MNU methylnitrosourea
NPC1L1         Niemann-Pick C1 like 1
SREBP-2 sterol regulatory-element binding protein 2
TNF tumour necrosis factor
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1 INTRODUCTION
It has been well-established that elevated serum cholesterol level is associated with
an increased risk for coronary heart disease (CHD). A 1-mmol/l reduction in serum
total cholesterol is associated with a 24.5% reduction in CHD mortality and 17.5% in
all-cause mortality (Gould et al. 2007). Several studies have shown that plant sterols
and  stanols  (collectively  referred  to  as  phytosterols  in  this  thesis)  can  efficiently
lower  serum  low-density  lipoprotein  (LDL)  level  by  reducing  the  absorption  of
cholesterol from the intestine. This characteristic of these plant derived compounds
has  tempted  the  food  industry  to  enrich  food  products  with  plant  sterols  and  plant
stanols.  These  enriched  food  products  are  known  to  customers  also  as  functional
foods. The first commercial phytosterol enriched food was the plant stanol enriched
Benecol®  margarine  (Raisio  Group,  Raisio,  Finland)  that  was  launched  onto  the
market  in  1995  in  Finland.  It  is  estimated  that  a  customary  intake  of  2.5  g/d  of
phytosterols  lowers  serum  LDL-cholesterol  (LDL-C)  concentration  up  to  10%,  and
only  marginal  additional  effect  is  achieved  with  greater  doses  (Katan  et  al.  2003).
The  European  Food  Safety  Authority  (EFSA)  has  approved  health  claims  for  plant
sterol  and  plant  stanol  enriched  products  to  lower  serum  LDL-C  (European
Commission Regulation 384/2010).
Whereas phytosterol could lower CHD risk by reducing serum LDL-C concentration,
the  effect  of  phytosterols  on  colon  cancer  is  not  well  understood.  Although  plant
sterols have been shown consistently to have positive effects in colon cancer cells in
vitro (Awad et al. 1996, Awad et al. 1998, Choi et al. 2003, Baskar et al. 2010), some
controversy  exists  in  the  evidence  provided  by  animal  studies  (Raicht  et  al.  1980,
Quilliot et al. 2001, Jia et al. 2006). A Dutch cohort study on cancer (Normén et al.
2001) showed that  a  high intake of  plant sterols  did not reduce the risk of  colon or
rectal  cancers  but  actually  found  a  positive  association  between  high  intake  of
sitostanol  and risk of  rectal  cancer in men. Although plant sterols  and stanols  have
been widely studied and they are generally considered safe, studies on the long-term
consumption  of  plant  sterols  and  stanols  in  humans  are  lacking.  The  safety
evaluation studies of plant sterols are described in more detail in the literature
review of the thesis.
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The  risk  of  developing  colorectal  cancer  increases  with  age.  Mutation  in  the
adenomatous polyposis coli (APC) tumor suppressor gene is required in developing
hereditary colon cancer (familial adenomatous polyposis, FAP), and is also found in
the majority of sporadic colorectal tumors (Powell et al. 1992). The incidence of APC
mutations in the colon increases at middle-age (Luebeck and Moolgavkar 2002) and
often at the same time consumption of phytosterol enriched products begins.
Therefore the tumor prone ApcMin  mouse  (Adenomatous polyposis coli, Multiple
intestinal neoplasia) serves a reasonable approach to study the effect of plant sterols
and  stanols  from  enrichment  on  intestinal  tumor  formation.  No  previous  studies
have reported the effect of plant sterols or stanols in the tumor prone ApcMin mouse,
which  is  a  widely  used  mouse  model  to  study  the  impact  of  diet  on  colon
carcinogenesis.
To study the effect of phytosterol from enrichment in ApcMin mice, commercial food
products enriched with plant sterols or plant stanols were added to the experimental
diets. This work elucidates the effects of phytosterol feeding on intestinal tumor
formation and cellular mechanisms related to intestinal tumorigenesis in the ApcMin
mouse. The effects of plant sterol and plant stanol feeding on sterol metabolism in
the mouse small intestine were also examined.  Finally, the intake of phytosterols
from natural  and enriched food sources was evaluated among the Finnish men and
women from the national FINDIET 2007 Survey. This was done to assess if Finnish
consumers  using  phytosterol  enriched  foods  followed  the  label  information  on
recommended phytosterol intake set by authorities.
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2 REVIEW OF LITERATURE
2.1 Plant sterols and stanols
2.1.1 Structure
Sterols  are  essential  molecules  in  cellular  structures  in  animals  and  plants.  Plant
sterols  are  structurally  similar  to  cholesterol  found  in  animals.  The  term  “plant
sterols”  is  commonly  used  to  indicate  a  group  of  plant  derived  sterols  that  are
composed of  a  tetracyclic  steroid ring with a side chain attached to C-17 (Figure 1).
Plant  stanols  are  saturated  forms  of  plant  sterols  with  no  double  bonds  in  the  ring
structure.  Over 40 plant sterols  have been identified in the nature,  the major plant
sterol  being  β-sitosterol  followed  by  campesterol  and  stigmasterol  (Law  2000).
Saturated plant sterols such as sitostanol and campestanol are less abundant. In the
present thesis, the term phytosterols is used to refer to both plant sterols and stanols,
and specific compound names are applied when necessary.
2.1.2 Food sources and dietary intake
Good natural sources of phytosterols are whole grains, vegetable, vegetable oils, nuts,
and  fruit,  and  the  intake  varies  from 150  to  400 mg/  day  in  a  typical  Western  diet
(Normén  et  al.  2001,  Katan  et  al.  2003,  Escurriol  et  al.  2009).  According  to  the
FINDIET 1997 Survey the mean intake of phytosterols from natural sources was 305
mg/d for men and 237 mg/d for women in Finland (Valsta et al. 2004).
For two decades,  functional  foods enriched with plant sterol  and stanol  esters have
been marketed for their beneficial effect on lowering plasma low-density lipoprotein
cholesterol (LDL-C). Phytosterol intake may notably increase when plant sterol and
stanol enriched functional foods are consumed. Simulation studies have suggested
that the potential daily intake of phytosterols could exceed 8 grams when phytosterol
enriched products were virtually replaced with conventional food products in the diet
(Raulio et al. 2001, De Jong et al. 2004, Kuhlmann et al. 2005).
15
Figure 1.Chemical structures of cholesterol and some phytosterols.
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The European Food Safety Authority (EFSA) has approved a health claim stating that
“Plant sterols and stanols lower blood cholesterol. High cholesterol is a risk factor
in the development of coronary heart disease.” (European Commission Regulation
No 384/2010). The approved food matrices regulated by EFSA (Regulation (EC) No
376/2010) include yellow fat spreads, dairy products, mayonnaise, and salad
dressings. Moreover the phytosterol enriched product should clearly state in the label
that the products are intended exclusively for people who want to lower blood LDL-C
levels, and they are not appropriate for pregnant and breastfeeding women and
children under the age of  five (Regulation (EC) No 608/2004).  Intakes above 3g/d
should not be recommended on the basis of the current scientific evidence on plant
sterols and stanols and their lowering effect on blood carotenoid levels (EFSA 2008).
Phytosterol  enriched  products  should  be  advised  to  be  consumed  as  a  part  of  a
balanced diet that includes fruit and vegetables to provide adequate carotene intake
(Regulation (EC) No 608/2004). Recently EFSA concluded that plant sterol and
stanol esters at an intake of 3.0 g/d (range 2.6-3.4 g/d) lower blood LDL-cholesterol
by  11.3%  at  similar  efficacy  when  used  for  at  least  for  two  to  three  weeks  (EFSA
2012).
In  the  USA,  Food  and  Drug  Administration  (FDA)  authorized  a  health  claim  that
plant  sterol  and  stanol  esters  reduce  the  risk  of  CHD,  and  the  US  National
Cholesterol Education Program recommend a daily intake of 2 g of plant sterols and
stanols  to  treat  high  cholesterol  levels  (NCEP  2002).The  advised  daily  dose  of
phytosterols according to manufacturers is around 2 g and often a daily dose of 2 g
can be achieved using a portion of youghurt drink.
2.1.3 Effects of phytosterols on serum cholesterol and phytosterols
Already in the 1950’s phytosterols were observed to lower blood cholesterol level and
reduce cholesterol absorption from the intestine (Peterson 1958). Since then the
effect  of  plant  sterols  and  stanols  on  blood  LDL  levels  has  been  verified  in  many
randomized control trials which have been summarized in many systematic meta-
analyses.  The  effect  of  phytosterols  on  serum LDL-C is  achieved  within  few weeks,
and  the  effect  has  been  shown  to  remain  stable  (Miettinen  et  al.  1995).  Katan  and
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coworkers  (Katan  et  al.  2003)  concluded  in  their  meta-analysis  of  41  randomized
trials that a daily intake of 2.5 g of plant sterols or stanols lowers serum LDL-C level
up  to  10%,  and  intakes  above  this  have  only  little  additional  effect.  In  the  meta-
analysis  conducted  few  years  later  by  Abumweis  and  coworkers  (Abumweis  et  al.
2008), 59 randomized placebo controlled clinical trials were included. A greater
decrease in LDL-C levels was observed in subjects with higher baseline levels
compared  with  those  with  lower  baseline  LDL-C  levels.  Furthermore,  a  dose-
response effect  was found and the maximum effect  on LDL-C was found with daily
doses greater than 2.5 g of phytosterols. The dose-response effect of phytosterol
intake  was  confirmed in  a  meta-analysis  by  Demonty  et  al.  (Demonty  et  al.  2009).
Overall, in 84 randomized trials that were included in their analysis, the mean daily
dose of 2.15 g of phytosterols resulted in 8.8% pooled LDL-C reduction.
Results from meta-analysis comparing the effect of plant sterols and plant stanols
separately  indicate  that  they  do  not  differ  in  the  LDL-C  lowering  effect  within  the
intake range of 0.6-2.5 g/d (Talati et al. 2010). The efficacy of plant sterols and plant
stanols may differ at high doses (Musa-Veloso et al. 2011). Recently, two studies on
the effect of high plant stanol intake have been conducted. Mensink and co-workers
(Mensink et al. 2010) found a dose-response relationship between plant stanol intake
and  LDL-C  reduction,  and  an  intake  of  9  g/d  lowered  LDL-C  by  17%  compared  to
control. Similarly, Gylling and her co-workers (Gylling et al. 2010a) showed a 17.4%
reduction in LDL-C at an intake of 8.8 g/d of plant stanols compared to control. In
contrast, a linear dose-response was not observed with plant sterols by Davidson et
al.  (Davidson  et  al.  2001).  In  the  meta-analysis  performed  by  Musa-Veloso  et  al.,
intakes  above  2  g/d  of  plant  stanol,  but  not  plant  sterol,  were  associated  with
additional and dose-dependent reductions in LDL-C (Musa-Veloso et al. 2011). The
number of high-dose studies in this meta-analysis was, however, limited.
Dietary  plant  sterols  are  poorly  absorbed  from  the  intestine.   In  comparison  to
dietary  cholesterol  of  which  35-70%  is  absorbed  (De  Jong  et  al.  2003),  5%  of  β-
sitosterol,  15%  of  campesterol  and  less  than  1%  of  plant  stanols  is  absorbed  (Law
2000). The serum phytosterol concentration is partly regulated by intestinal
absorption  and  partly  by  excretion  in  bile  back  to  the  intestine  (Miettinen  et  al.
2000). In the normal population,  serum plant sterol concentrations vary between 3
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and  21  μM  and  plant  stanol  concentrations  between  0.05  and  0.3  μM  when
phytosterol  enriched  foods  are  not  consumed  (Gylling  and  Miettinen  2010).
Customary use of phytosterol enriched products increases serum plant sterol
concentrations but plant stanol concentrations are increased only slightly (Fransen et
al.  2007,  Kratz  et  al.  2007,  Gylling  et  al.  2010a).  Furthermore,  plant  stanol
supplementation  decreases  serum  plant  sterol  concentrations  (Kratz  et  al.  2007,
Gylling et al. 2010a).
2.1.4 Phytosterols and CHD
In  2010,  EFSA  approved  a  health  claim  for  plant  sterol  and  stanol  ester  enriched
products  to  lower  serum  LDL-C  as  part  of  a  healthy  diet  (European  Commission
Regulation 2010/384). Data from drug studies suggest that a 10% reduction in LDL-
C levels could reduce the incidence of ischaemic heart disease by 12% to 20% over 5
years;  however  no  trials  have  tested  the  effects  of  phytosterols  on  coronary  heart
disease incidence. Dietary phytosterols has been found to reduce atherosclerosis
plaque  formation  for  instance  in  apo  E  -deficient  mice  when  consumed  along  with
high cholesterol diet (Xu et al. 2008).
Elevated  concentrations  of  serum  plant  sterols  are  found  in  subjects  with
sitosterolemia (phytosterolemia), a rare genetic disorder where the sterol
transporters  ABCG5/8  are  affected  (Lee  et  al.  2001).  In  these  patients,  serum  and
tissue plant sterol concentrations are 10-25 higher than in unaffected individuals,
whereas serum cholesterol concentrations are normal or moderately increased (Lee
et al. 2001). Since sitosterolemic patients suffer from premature atherosclerosis and
coronary artery disease, high serum phytosterol concentration has been suggested as
a risk factor of  atherosclerosis.  Even in normal subjects,  elevated concentrations of
plasma plant sterols have been associated with increased risk for coronary events
(Assmann  et  al.  2006).  The  variation  in  serum  phytosterol  levels  in  general
population is caused by genetic variants in ABCG transporters (Teupser et al. 2010).
The  polymorphisms  of  ABCG8  that  are  associated  with  elevated  serum  phytosterol
concentrations have been found to be associated with an increased risk of  coronary
artery disease (Teupser et al. 2010). A systematic literature review and meta-analysis
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based on 17 studies found, however, no association between serum phytosterol levels
and risk for cardiovascular diseases (CVD) (Genser et al. 2012). Studies included in
the meta-analysis reported inconsistent findings on moderately elevated levels of
serum sitosterol and campesterol and CVD risk, but the effects of long-term
consumption of plant sterol enriched foods have not been assessed.
2.1.5 Effects of phytosterols on cholesterol metabolism in the intestine
The  intracellular  free  cholesterol  pool  is  tightly  regulated  by  a  network  of  proteins
and transcription factors that respond to cellular free cholesterol content. When free
cholesterol  concentration  drops  below  a  threshold  level,  the  sterol  regulatory-
element binding protein 2 (SREBP-2) transcription factor is activated and
translocated  from  the  endoplasmic  reticulum  via  Golgi  to  nucleus  where  its  target
genes are regulated (Brown and Goldstein 1997). The targets of SREBP-2 transcribe
proteins that induce cholesterol synthesis (e.g. 3-hydroxy-3-methylglutaryl-CoA-
reductase, HMGCR; farnesyl diphosphate synthase, and squalene synthase), and
increase transport of cholesterol into the cell via LDL-receptor (Horton et al. 2002).
In contrast, when cellular free cholesterol concentration is increased, the expression
of proteins that regulate cholesterol efflux is activated through an orphan nuclear
receptor  LXR  mediated  transcription  of  target  genes  such  as  ATP-binding  cassette
(ABC) transporters ABCG5, ABCG8 and ABCA1 (Ory 2004).
The balance in whole-body cholesterol pool is regulated by absorption of dietary and
biliary  cholesterol,  excretion  of  cholesterol  into  the  bile  and de novo synthesis of
cholesterol. Disruption of processes regulating whole-body cholesterol homeostasis
influences circulating cholesterol levels, and therefore treatment that targets LDL-C
levels have been developed. Whereas cholesterol-lowering statins inhibit the
synthesis of cholesterol, phytosterols primarily lower serum LDL-cholesterol level by
reducing  the  absorption  of  dietary  and  biliary  cholesterol  in  the  small  intestine.
Several mechanisms have been suggested how plant sterols and stanols reduce
cholesterol absorption (Figure 2). In the intestinal lumen, phytosterols compete with
cholesterol for incorporation into mixed micelles (Ostlund et al. 1999, Nissinen et al.
2002,  Mel’nikov  et  al.  2004).  Since  phytosterols  are  more  hydrophobic  than
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cholesterol they displace cholesterol from the micelles reducing the absorption of
cholesterol.
In addition to replacing cholesterol from micelles, phytosterols may reduce
cholesterol  absorption  within  the  enterocyte.  Plat  et  al.  (Plat  et  al.  2000)
demonstrated that reduction in absorbed cholesterol did not require simultaneous
consumption of dietary cholesterol and plant stanols since plant stanols in one daily
dose  had  a  similar  effect  on  serum  LDL-C  level  as  several  doses  of  plant  stanols
during  the  day.  This  finding  suggested  that  phytosterols  could  regulate  cholesterol
absorption  in  long-term.  To  date,  several  studies  have  shown  that  this  long-term
effect may be related to the regulation of cholesterol metabolism in the enterocyte.
These mechanisms include the transport of cholesterol in and out of the enterocyte.
The  intestinal  absorption  of  free  cholesterol  and  phytosterols  is  mediated  by  the
Niemann-Pick C1 like 1  (NPC1L1) transporter protein found on the brush border of
enterocytes (Davis and Altmann 2009, Jia et al. 2011). NPC1L1 may contribute to the
selective  transport  of  cholesterol  and  phytosterols   into  the  enterocyte  (Jia  et  al.
2011) and certain plant sterols have been found to down-regulate NPC1L1 expression
in cultured intestinal epithelial cells (Jesch et al. 2009).
Phytosterols may also regulate the efflux of cholesterol from enterocytes. In 2002,
Plat  and  co-workers  demonstrated  that  plant  stanol  supplementation  increased  the
expression of ABCA1 transporter in CaCo-2 cells, a model for intestinal epithelial
cells  (Plat  and  Mensink  2002).  At  that  time,  the  authors  suggested  that  ABCA1
mediated the efflux of cholesterol into the intestinal lumen; however, ABCA1
transporter  is  currently  supposed  to  localize  on  the  basolateral  membrane  of
enterocytes (Ohama et al. 2002) and transport sterols to HDL (Murthy et al. 2002).
The  export  of  sterols  back  into  the  intestinal  lumen  is  mediated  by  heterodimeric
transporters  ABCG5  and  ABCG8  localized  on  the  apical  membrane  of  enterocytes
(Tachibana  et  al.  2007).  These  transporters  are  also  expressed  on  the  canalicular
membrane of hepatocytes, regulating the removal of cholesterol and phytosterols
into the bile (Graf et al. 2003). Mutations that lead to functional defects in ABCG5/8
transporters  are  found  in  individuals  with  sitosterolemia,  where  the  absorption  of
phytosterols is increased (Lee et al. 2001). Findings on whether phytosterols reduce
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cholesterol absorption by regulating ABCG5/8 transporters are conflicting. Although
phytosterols  have  been  demonstrated  to  act  as  potent  activators  of  LXR  in  CaCo2
human  intestinal  cell  line  (Plat  et  al.  2005),  plant  sterol  or  stanol  feeding  did  not
activate the known LXR target genes, such as ABCG5/8  in the mouse intestine (Field
et  al.  2004,  Calpe-Berdiel  et  al.  2005,  Plösch  et  al.  2006).  Reduction  in  the
expression levels of intestinal ABCG5/8 after plant sterol feeding to mice has also
been reported (Brufau et  al.  2011).  Recently,  plant sterols  were found to reduce the
activity of CYP27 enzyme that converts sterols into 27OH metabolites that are potent
activators  of  LXR  (Brauner  et  al.  2012).  Consequently,  plant  sterols  reduced  LXR
activation and ABCA1 expression with no change in ABCG8 expression in CaCo-2
cells. The authors concluded that in enterocytes plant sterols reduce cholesterol
absorption by upregulating ABCA1 pathway.
Furthermore,  plant  sterols  have  been  shown  to  inhibit  the  activity  of  acetyl-
CoA:cholesterol acyltransferase-2 (ACAT-2) that esterifies free cholesterol to fatty
acids in the enterocyte (Igel et al. 2003). As only esterified sterols are incorporated
into  chylomicrons,  the  absorption  of  cholesterol  is  thereby  reduced  (Fig.  2).  Plant
sterols  and stanols  themselves are poorly esterified by ACAT (de Jong et  al.  2003),
which in part also explains the poor absorption of these compounds.
In addition, β-sitosterol supplementation to CaCo-2 cells has been reported to down-
regulate the activity of HMGCR, the key enzyme in cholesterol synthesis (Field et al.
1997). By contrast, sitosterol feeding to rats up-regulated HMGCR activity and
receptor-mediated  LDL binding  with  no  change  in  cholesterol  concentration  in  the
intestinal  mucosa  (Nguyen  et  al.  2001).  Similary,  plant  sterol  feeding  to  mice
increased  mRNA  levels  of  Hmgcr  in  enterocytes  (Brufau  et  al.  2011).  It  seems  that
compensatory mechanisms are activated to produce endogenous cholesterol when
cholesterol  absorption  is  reduced.  Individual  plant  sterols  may,  however,  have
specific effects on cholesterol metabolism: whereas β-sitosterol did not displace
cholesterol from the plasma membrane and activate ACAT, campesterol induced
influx of membrane cholesterol  and ACAT activity (Field et al. 1997).
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Figure 2. Mechanisms by which phytosterols possibly reduce cholesterol absorption.
Taken together, it is clear that plant sterols and plant stanols affect cellular
cholesterol  metabolism,  but  the  exact  mechanism  how  cholesterol  absorption  is
reduced at the cellular level needs still to be discovered. Findings from in vitro and in
vivo experiments are inconsistent when the effect of plant sterols/ stanols on cellular
cholesterol homeostasis is studied. First, absorption of cholesterol by enterocytes in
vivo and uptake of sterols by cultured cells are not comparable. Second, the effect of
phytosterols on intestinal cholesterol metabolism in animals can be both direct and
indirect. Direct actions of phytosterols include functioning as a signaling molecule as
such,  (Park  and  Carr  2013),  acting  as  a   ligand  for  transcription  factors  (Plat  et  al.
2005), or replacing cholesterol at the plasma membrane (Awad et al. 1996). Indirect
mechanisms involve activated cellular mechanisms to compensate for reduced
cholesterol absorption (Nguyen et al. 2001). When phytosterols are supplemented to
cultured cells, phytosterols affect cellular metabolism more or less directly. In
addition, a mixture of phytosterols may affect cholesterol metabolism differentially
when compared with individual phytosterols.
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2.1.6 Effects of phytosterols on cholesterol metabolism in the liver
The liver is a central player in the whole-body cholesterol homeostasis regulating the
cholesterol  levels  in  the  circulation.  In  order  to  compensate  for  the  reduction  of
absorbed cholesterol in circulating chylomicrons after phytosterol ingestion,
hepatocytes upregulate the LDL receptor mediated uptake of cholesterol. As a
consequence of reduced cholesterol absorption, blood LDL-C levels are reduced.
However, decreased circulating cholesterol levels have also been observed after
injection  of  phytosterols  (Vanstone  et  al.  2001),  and  therefore  phytosterols  may
affect LDL-C levels via mechanisms that do not involve intestinal cholesterol
absorption.
In general, endogenous cholesterol synthesis is increased after phytosterol
consumption, which seems to be a compensatory mechanism to regulate whole-body
homeostasis when cholesterol absorption is reduced. This has been observed both in
humans  and  animals  after  phytosterol  consumption  (Vanhanen  et  al.  1993)
(Moghadasian  et  al.  2001,  Mensink  et  al.  2002,  Batta  et  al.  2005,  Harding  et  al.
2010). In addition, phytosterol feeding increases plant sterol and stanol
concentrations in the liver (Awad et al. 1997a, Chen et al. 2009, Harding et al. 2010,
Rideout et al. 2010, Weingärtner et al. 2011).
The  changes  in  sterol  metabolism may  be  influenced  by  phytosterol  per  se  or  their
hypocholesterolemic effect depending on the model where phytosterols are studied.
In  wild-type  mice,  circulating  cholesterol  is  mainly  transported  in  HDL  unlike  in
humans (Jawień et al. 2004), and although phytosterol feeding reduces cholesterol
absorption, it does not affect serum non-HDL cholesterol levels in mice (Calpe-
Berdiel et al. 2005). In C57BL/6J mice without genetic defects in sterol metabolism,
phytosterol feeding has been demonstrated to upregulate levels of hepatic Hmgcr
(Harding  et  al.  2010),  Abcg5  (Plösch  et  al.  2006,  Harding  et  al.  2010),  Abca1,  and
Cyp27a1 (Harding et al. 2010) without affecting blood cholesterol levels.
Phytosterol feeding lowers plasma cholesterol levels in hamsters (Ntanios and Jones
1999), apoE-/- mice (Calpe-Berdiel et al. 2005, Weingärtner et al. 2011), and LDLR-/-
mice (Calpe-Berdiel et al. 2005). Lowered levels of serum LDL-C are often
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accompanied  with  reduced  cholesterol  concentration  in  the  liver   (Trautwein  et  al.
2002, Calpe-Berdiel et al. 2005, Weingärtner et al. 2011), and increased hepatic
Abcg5,  Abcg8,  and  Npc1l1  expression  (Calpe-Berdiel  et  al.  2005,  Harding  et  al.
2010).  Increase  in   the  activity  or  protein  levels  of  the  hepatic  Hmgcr  after
phytosterol consumption have been widely reported in these animal models
(Moghadasian et al. 2001, Batta et al. 2005, Xu et al. 2008, Harding et al. 2010).
In summary, phytosterols affect hepatic expression of genes related to cholesterol
metabolism. The impact of phytosterol feeding on hepatic genes may be associated
with changes in serum LDL-C. However, for instance, increased expression of Hmgcr
after  phytosterol  ingestion  has  been  observed  with  (apoE-/- mice) or without (wild-
type mice) changes in serum LDL-C.
2.1.7 Safety of phytosterols
Plant  sterols  have  toxic  effects  in  mice  with  genetic  defects  in  Abcg5/8.  Recently  it
was shown that  a  0.2% plant sterol  enriched diet  increased liver mass and induced
liver damage caused by accumulation of hepatic plant sterols (McDaniel et al. 2013).
In addition, these mice developed severe myocardiac lesions after plant sterol
feeding. The loss of normal function in the ABCG5/8 sterol transporters leads to high
serum plant sterol concentrations in sitosterolemic patients, and premature
atherosclerosis is common (Lee et al. 2001). To avoid the consequences of enhanced
sterol absorption, sitosterolemia is treated by dietary restirictions (a sterol poor diet)
and  by  medication  that  inhibits  sterol  absorption  (e.g.  ezetimibe)  or  synthesis
(statins).
Series of studies evaluating the safety of phytosterols have been conducted in animals
and humans without mutations in the ABCG5 or ABCG8 transporter. The toxicity of
a mixture of phytosterol esters was studied in doses up to 8.1% of diet for 90 days in
male  and  female  rats  (Hepburn  et  al.  1999).  Plant  sterols  had  no  effect  on  weight
development,  food  or  water  consumption,  or  organ  weights.  Some  minor  changes
were observed in haematological and clinical parameters, but these changes were not
considered  of  toxicological  importance.  Later,  the  relative  absorption  and  tissue
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distribution of β-sitosterol, β-sitostanol, campesterol, campestanol, and stigmasterol
were studied in the rat (Sanders et al. 2000). Although the absorption of phytosterols
was low, some tissues showed increased accumulation of phytosterols. Increased
accumulation  of  phytosterols  was  observed  in  adrenal  glands,  ovaries,  lungs,  liver
and  intestinal  tissue.  Most  of  the  administered  phytosterols  were  excreted  in  the
feces (Sanders et al. 2000).
No  adverse  effects  of  phytosterols  were  seen  on  the  reproduction  physiology  and
sexual maturation in male and female rats in studies carried with two generations of
rats.  The  dose  of  plant  sterol  esters  varied  up  to  8.1%  (Waalkens-Berendsen  et  al.
1999)  and  plant  stanol  esters  up  to  8.8%  (Whittaker  et  al.  1999).  Some  adverse
effects were reported, not conclusively related to the treatment: some females in
plant sterol and stanol groups delivered only dead pups (Waalkens-Berendsen et al.
1999) (Whittaker et  al.  1999),  and two females fed plant stanol  at  low- or mid-dose
exhibited histological changes in the uterus, including metaplasia and early
carcinoma (Whittaker et al. 1999). Furthermore, the body weight was significantly
decreased in pups in the high-dose group which was attributed to a reduced caloric
intake  (Whittaker  et  al.  1999).  Plant  sterols  or  plant  stanols  have  not  been  proven
estrogenic in vitro or in vivo (Baker et  al.  1999,  Turnbull  et  al.  1999).  More on the
estrogenic  effect  of  plant  sterols  are  described  in  the  section  “Phytosterols  as
phytoestrogens”.
The effect of dietary phytosterols on fecal concentrations of bile acids and sterols was
studied in men and women (Weststrate et  al.  1999).  Intake of  8.6 g of  plant sterols
from  a  test  margarine  significantly  increased  concentrations  of  neutral  sterols  and
neutral  sterol  metabolites  in  the  feces,  whereas  faecal  secondary  and  total  bile  acid
concentration was reduced. Dietary plant sterols increased the faecal concentration
of 4-cholesten-3-one in both men and women, but the effect was significant only in
women. 4-Cholesten-3-one is a breakdown metabolite produced from cholesterol by
intestinal microflora, and it has been reported mutagenic (Suzuki et al. 1986, Kaul et
al. 1987). The mutagenic potential of plant sterols and 4-cholesten-3-one was studied
by Wolfreys and Hepburn as a part of the safety evaluation program of phytosterols
(Wolfreys and Hepburn 2002). The treatment with plant sterols, plant sterol esters,
or 4-cholesten-3-one did not increase chromosome aberrations in human peripheral
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blood  lymphocytes,  nor  did  plant  sterols  induce  cytotoxicity  in  mouse  lymphoma
cells  or  in  the  rat  bone  marrow.  In  addition,  plant  stanol  esters  were  tested  for
genotoxicity  in  bacterial  and  mammalian  cells  and  were  not  found  genotoxic
(Turnbull et al. 1999).
Oxidation  products  of  cholesterol  and  phytosterols  have  been  documented  to  be
cytotoxic in vitro (Adcox et al. 2001, Roussi  et  al.  2005,  Ryan  et  al.  2005). The
reported cytotoxic effects included increased cell death by apoptosis or necrosis
(Ryan et al. 2005), decreased cell viability, and loss of membrane integrity (Adcox et
al.  2001).  Lea  et  al.  reported  no  genotoxic  effects  of  a  mixture  of  oxidized  plant
sterols in vitro (Lea et  al.  2004).  When oxidized plant sterols  were administered in
the diet in concentrations up to 1.6% for 90 days, no adverse effects were detected in
haematological and clinical parameters, or in weights of selected organs in male and
female rats. Only liver weights were significantly increased in females that were fed
oxidized plant sterols at 1.6% of the diet when compared with control and plant sterol
diet (Lea et al. 2004).
The reduction in serum β-carotene level is a widely reported side-effect of
phytosterol  consumption  (Mensink  et  al.  2002,  Gylling  et  al.  2010b,  Heggen  et  al.
2010, Hernández-Mijares et al. 2011). Serum levels of vitamin A, the end of product
β-carotene,  have  been  reported  to  remain  unaffected  (Gylling  et  al.  2010b).  This
reduction  in  circulating  β-carotene  may  result  from  decreased  absorption  of
carotenoids from the intestine or lower level of LDL particles in the circulation after
phytosterol consumption.
2.1.8 Phytosterols as phytoestrogens
The estrogenic potential of phytosterols has been studied in vitro and in vivo. The
results are inconsistent and so far phytosterols are not regarded as strong
phytoestrogens as e.g. isoflavones and lignans. Some studies suggest that
phytosterols alter sex steroid hormone levels (Nieminen et al. 2003, Ju et al. 2004),
but also no effects on hormone levels have been reported (Ayesh et al. 1999).
Phytosterols have been shown to bind estrogen receptors (ER) (Gutendorf and
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Westendorf 2001, Newill et al. 2007) with low affinity with better binding affinity to
ERβ than to ERα (Gutendorf and Westendorf 2001). Not all studies confirm binding
of phytosterols to ER (Baker et al. 1999). Baker et al. used a mixture of plant sterols
(47.9% β-sitosterol, 28.8% campesterol, 23.3% stigmasterol) and found no binding of
plant  sterols  to  estrogen  receptors  nor  did  plant  sterols  compete  with  estradiol  for
binding  to  the  ER  (Baker  et  al.  1999).  In  addition,  plant  sterols  did  not  produce
transcriptional activity of the human ER in yeast, or affected the growth of estrogen-
responsive tissue in vivo (Baker  et  al.  1999).  Similarly,  high  plant  stanol  intake
(mixture of plant stanols) has not proven to be estrogenic in rats (Turnbull et al.
1999).  Findings by Ju and coworkers (Ju et al. 2004) indicate that β-sitosterol may,
however, exert estrogenic activity, and stimulate the growth of MCF-7 human
estrogen-responsive  breast  cancer  cells.  Studies  on  stigmasterol  and  its  oxidation
products suggest that oxidized stigmasterols bind to ER with week affinity, and by
displacing estradiol from ER these compounds interfere with hormone signaling
(Newill et al. 2007). So far, phytosterols per se have not been shown to activate the
transcriptional targets of estrogens. Overall, the estrogenic effects appear to be
different between individual phytosterols and the effects seem to be model-
dependent.
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2.2 Colon carcinogenesis
2.2.1 Colorectal cancer
Colorectal cancer is the third most common cancer in men (10.0% of the total cancer
incidence) and the second in women (9.4% of the total cancer incidence) in the world
(IARC 2008). In 2008, over 1.2 million people worldwide were given the diagnosis of
colorectal cancer. About 608 000 deaths from colorectal cancer are estimated
worldwide,  accounting  for  8%  of  all  cancer  deaths,  making  it  the  fourth  most
common  cause  of  death  from  cancer.  Almost  60%  of  the  cases  occur  in  developed
regions.  Ethnic,  migrant  and  twin  studies  suggest  that  environmental  and  lifestyle
factors, including diet, play a pivotal role in the etiology of CRC. It is estimated that
dietary  factors  could  contribute  to  CRC  incidence  by  30%-50%  (Vargas  and
Thompson 2012). The evidence on lifestyle factors and CRC risk is covered
thoroughly in the report of the World Cancer Research Fund (WCRF/IARC 2011).
Majority (75%) of colon cancers develops sporadically and the remaining colon
cancer cases are caused by an inherited predisposition (Boyle and Levin 2008). The
most common inherited colon cancer syndromes are familial adenomatous polyposis
(FAP),  hereditary  non-polyposis  colorectal  cancer  (HNPCC),  also  known  as  the
Lynch syndrome, and MUTYH-associated polyposis (MAP). Patients with FAP carry
an  inherited  germline  mutation  in  the APC tumor-suppressor gene that causes
development of hundreds to thousands of adenomas in the colon and rectum in early
age  (Kinzler  and  Vogelstein  1998).  Lynch  syndrome  is  caused  by  mutations  in
mismatch repair genes (Peltomäki 2001). In addition to colorectal cancer people with
Lynch syndrome develop cancer in other organs.
Mutations in the APC gene are common in non-inherited colon cancers, too, and the
incidence of APC mutations  in  the  colon  increases  at  middle-age  (Luebeck  and
Moolgavkar 2002). Approximately, 70-80% of sporadic colorectal adenomas and
carcinomas have somatic APC mutations (Fearon 2011). Adenomas, or adenomatous
polyps,  are tumors that  develop from glandular epithelium, and they seem to be an
important precursor of colorectal cancer (Fearon 2011); however, small amount of
adenomas develop into malignant carcinomas. The process of a dysplastic cell to turn
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into  a  carcinoma  is  a  multistep  sequence  that  involves  mutations  in  other  tumor-
suppressor genes and proto-oncogenes, as well as alterations in the genomic
stability.  These  transformations  in  the  genome  lead  to  disturbed  regulation  of  cell
growth and differentiation,  and eventually  to the development of  an early adenoma
to a metastatic tumor (Figure 3.).
Figure  3.  The  multistep  development  of  colon  cancer.  Mutations  in  tumor-
suppressors and proto-oncogenes are involved in the adenoma-carcinoma sequence.
Changes in DNA methylation and genomic instability contribute to the malignant
transformation. (Adapted from Fearon and Vogelstein 1990, and Fearon 2011).
2.2.2 Construction and maintenance of intestinal epithelium
The epithelial cells in the intestine are under a rapid but steady process of renewal.
While  new  cells  are  generated  in  the  intestinal  crypts,  old  cells  are  removed  by
shedding  from  the  tips  of  villi.  The  intestinal  epithelium  is  constructed  of
invaginations called crypts, and intestinal stem cells responsible for tissue
regeneration are located in the lower part of the crypts (Clevers 2013). Epithelial cells
produced  by  the  stem  cell  daughters  migrate  toward  the  upper  part  of  crypt  and
villus  where  they  lose  their  capacity  to  divide  and  start  to  differentiate.  The
differentiated cells found in the colon and in the small intestine are the predominant
enterocytes, mucus-producing Goblet cells, and the peptide hormone secreting
enteroendocrine  cells.  In  the  small  intestine,  cells  migrating  down  the  crypt
differentiate into Paneth cells that modulate innate immune system (Santaolalla and
Abreu 2012).
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The homeostasis in the intestinal epithelium is tightly regulated by maintaining a
balance between proliferative and anti-proliferative signals (reviewed by Crosnier et
al.  2006 and Clevers 2013).  The Wnt and Notch signaling play a pivotal  role in the
proliferation  and  maintenance  of  intestinal  stem cells  (Clevers  2013).  On the  other
hand,  anti-proliferative  signals  such  as  the  Hedgehog  and  bone  morphogenetic
proteins  (BMP)  repress  Wnt  signaling  and  stem  cell  proliferation  (Crosnier  et  al.
2006). Cell proliferation is regulated by signals received from the cell
microenvironment. Neighboring cells may activate Notch signaling in intestinal stem
cells  and  through  Wnt  signaling  maintain  the  proliferative  state  of  stem  cells
(Medema and Vermeulen 2011). The BMP’s are secreted by the mesenchymal
microenvironment  and  their  signaling  is  active  in  differentiated  cells  along  the
epithelial lining (Medema and Vermeulen 2011).
The lifespan of an intestinal cell is only few days long (Näthke 2004), and  the active
clearance of cells protects the intestinal epithelium from oncogenic mutations.
However, the rapidly renewing tissue appears to be a potential target for mutational
changes.  Several  theories  on  the  primary  cells  for  oncogenic  transformation  in  the
intestinal epithelium have been proposed. Whether oncogenic mutations accumulate
in the founder stem cells or in the stem cell daughters in intestinal crypts have been
suggested (the bottom-up model), but initiating transformation of migrated and
differentiated cells have been proposed (the top-bottom model), too (reviewed by
Medema and Vermeulen 2011). Despite the controversies on the site of the
transformation, growing evidence supports the model that human cancers arise from
cancer stem cells that are capable of initiating and sustaining tumor growth (Clevers
2011,  Verga  Falzacappa  et  al.  2012).  Like  stem  cells,  cancer  stem  cells  have  the
potential  of  self-renewal,  as  well  as  the  ability  to  expand and  differentiate  (Clevers
2011).  The  generation  of  colon  cancer  stem cells  is  dependent  on  genetic  factors  as
well  as  micro-environmental  signaling  (Medema  and  Vermeulen  2011,  Verga
Falzacappa et al. 2012). Cancer stem cells produce a progeny of cells that forms the
bulk  of  the  tumor,  and  a  single  tumor  may  have  subclones  of  multiple  cancer  stem
cells (Clevers 2011).
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2.2.3 Apoptosis
Programmed  cell  death  by  apoptosis  is  important  in  maintaining  homeostasis  in
tissues with rapid cell turnover such as the intestinal epithelia. Apoptosis regulates
the removal of normal and transformed cells and acts as a natural barrier for cancer
development. Resistance of cell death is a trait that cells have to acquire during the
process of  cancer,  and this  is  established by mutations in the regulatory machinery
(Hanahan and Weinberg 2011).
The apoptosis pathway involves the up-stream regulators, which can be extracellular
(extrinsic pathway) or intracellular (intrinsic pathway), and the down-stream
effectors.  The  extrinsic  pathway  is  activated  by  death  receptor  ligation,  such  as
binding  of  Fas  or  TNF  ligand  to  its  receptor  that  subsequently  activates  caspase-8
(Wen et al. 2012). The intrinsic pathway, also named as the mitochondrial pathway,
is initiated by intracellular stress that activates caspase-9 (Wen et al. 2012). Both the
extrinsic and intrinsic pathways activate the down-stream effector caspase-3 that is
responsible for the final execution of apoptosis. The signaling between the regulators
and effectors is mediated by the Bcl-2 subfamily of pro-apoptotic (Bax, Bak, Bad, Bcl-
X, Bid, Bik) and anti-apoptotic (Bcl-2, Bcl-XL, and Mcl-1) proteins. The pro-apoptotic
proteins induce apoptosis by facilitating the release of cytochrome c from
mitochondria which activates caspase-9, whereas anti-apoptotic proteins inhibit
apoptosis by binding of pro-apoptotic proteins (Adams and Cory 2007). A key sensor
that responds to cellular abnormalities, such as DNA damage, hypoxia, and reduced
nutrient  supply,  is  the  p53  tumor  suppressor  (Fearon  2011)  (Sperka  et  al.  2012).
Mutations in the p53 gene  are  common  in  human  CRC  tumors  and  are  associated
with increased invasiveness (Fearon 2011).
2.2.4 Cell cycle regulation
In  order  to  divide  cells  have  to  increase  their  mass  and  replicate  their  DNA.  The
consecutive processes and phases that lead to cell division are called the cell cycle,
which is regulated by a machinery of proteins. The entry from one phase to another
is controlled by several check-points along the cell cycle. The check-points respond to
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mitogenic  signals  such  as  growth  factors  that  promote  cell  division.  In  addition,
check-points sense genetic errors that can be then repaired or alternatively the
damaged cell is eliminated by apoptosis. Proteins that regulate the progression of cell
cycle at the checkpoints are the cyclins, the cyclin dependent kinases, the cyclin
dependent kinase inhibitors,  the Retinoblastoma (Rb) complex,  and the E2F family
of transcription factors (reviewed by Satyanarayana and Kaldis 2009). Deregulation
of  the  cell  cycle  leads  to  uncontrolled  cell  growth  (increase  in  cell  mass)  and  cell
proliferation (increase in cell number).
Rapidly  dividing  cells  in  organs  with  high  cell  turnover,  such  as  the  intestine,  are
more  susceptible  to  DNA  damages  than  cells  in  quiescent,  non-dividing  state.
Mechanisms that eliminate DNA damages (i.e. gene mutations) have evolved to
maintain  cell  homeostasis.  As  a  consequence  of  DNA  damage  signaling  pathways
that  regulate  the  activation  of  checkpoints,  cell  cycle  progression,  DNA  repair  and
apoptosis  are  activated   (Patil  et  al.  2013).   The  DNA damage  kinases  ATM (ataxia
telangiectasia mutated) and ATR (ATM and Rad3 related) activate DNA damage
checkpoints and phosphorylate their downstream targets such as checkpoint kinase 1
and 2 (Chk1,  Chk2).  Activation of  Chk1 leads to cell  cycle arrest  by inhibiting PLK1
(polokinase 1), DNA repair, and cell death by apoptosis independent of p53 (Patil et
al.  2013).  Chk2  phosphorylates  p53  leading  to  cell  cycle  arrest,  DNA  repair  or
elimination  of  the  damaged  cell  by  apoptosis  (as  described  in  the  previous  section
“Apoptosis”). p53-mediated cell cycle arrest is primarily elicited by p21 that inhibits
the G1/S transition and therefore prevents replication of damaged DNA (Helton and
Chen 2007). Furthermore, p53 regulates the transcription of genes involved in DNA
repair  such  as  the  mismatch  repair  genes  (Helton  and  Chen  2007).  As  already
mentioned, mutations in the p53 are common in human CRC (Fearon 2011).
2.2.5 Colon cancer and the APC protein
The APC gene  is  a  tumor-suppressor  essential  to  normal  cell  growth.  The  gene
encodes  APC protein  that  acts  as  a  “gate-keeper”  of  the  genome.  In  sporadic  colon
cancer, APC mutations are associated with the early stages of tumorigenesis (tumor
development) (Fearon 2011), but in order to promote tumor development, both APC
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alleles have to be inactivated according to the Knudsen two-hit-model  (Kinzler and
Vogelstein  1996).  Once  both  alleles  have  been  inactivated  by  somatic  mutations  or
epigenetic  alterations,  the  tumor-suppressive  function  of  normal  APC  is  lost.
Disturbed function of APC protein results in the activation of the Wnt pathway that
mediates proliferative signaling. On the other hand, Wnt signaling plays a crucial
role in the regulation of cell proliferation as a morphogen during embryogenesis and
organ development (Clevers and Nusse 2012). Balanced Wnt signaling  is also a key
regulator in the maintenance of intestinal stem cells in the intestinal crypts (Clevers
2013).  The  abnormal  activation  of  Wnt  singaling  is  considered  an  initiating  step  in
the colon carcinogenesis (Bienz and Clevers 2000, Näthke 2004).
APC protein has multiple functions in the cell regulating cell migration, cell adhesion
and mitosis (Näthke 2004). One of its tasks is to regulate the β-catenin-dependent
Wnt  signaling  pathway  which  is  thoroughly  reviewed by  Clevers  and  Nusse  (2012).
The  APC  protein  forms  a  multiprotein  complex  with  glycogen  synthase  kinase  3β
(GSK3β)  and  axin  that  by  binding  together  promote  the  phosphorylation  and
degradation of  β-catenin by ubiquitin/ proteasome pathway (Fig.  4).  A mutation in
the APC gene  leads  to  a  truncated  form  of  the  APC  protein  that  no  longer  can
function normally. The absence of normal APC leads to activation of β-catenin-
dependent Wnt signaling with concomitant down-regulation of β-catenin
degradation and its accumulation in the nucleus. In the nucleus, β-catenin interacts
with the Tcf/Lef transcription factor, and regulates transcription of genes e.g. c-myc
and cyclin D1 (He et  al.  1998,  Shtutman et  al.  1999) that  enhance cell  proliferation
and growth.
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Figure 4. The Wnt – β-catenin pathway in normal colonic epithelial cells (A) and in
APC mutated colon cancer cells  (B).  Adapted from Narayan and Roy (Narayan and
Roy 2003).
2.2.6 Colon cancer and EGFR signaling
The  activation  of  the  ERK  MAPK  pathway  plays  an  important  role  in  cell
proliferation  in  colorectal  cancer.  ERK  is  activated  by  growth  factor  signaling  and
proto-oncogenes contributing to increased cell proliferation (Fang and Richardson
2005).  Mitogen-activated  protein  kinase  (MAPK)  signaling  occurs  in  response  to
almost  any  change  in  the  extracellular  or  intracellular  milieu.  MAPK  regulates  cell
growth, differentiation, cell survival, neuronal function and the immune response by
responding to growth factors, hormones, cytokines and stress (Yang et al. 2013).
One  mechanism  that  activates  ERK  in  colon  carcinogenesis  is  the  activation  of
epidermal growth factor receptor (EGFR) signaling. EGF receptors are tyrosine
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kinase  receptors  that  are  located  on  the  plasma  membrane  in  lipid  rafts  rich  in
cholesterol and sphingolipids (Pike 2005, Patra 2008, Balbis and Posner 2010).
Upon ligand binding EGFR is activated by phosphorylation of the tyrosine residues.
Activated EGFR recruits several downstream targets and activates signaling through
phosphorylation. These downstream signaling pathways include Ras/Raf/MEK/
ERK1/2,  but  also  the  PI3K/Akt  pathway.  Through  these  two  pathways  EGFR
regulates  the  homeostasis  between  cell  proliferation  and  maturation  in  the  gut
(Prenzel et al. 2001, Krasinskas 2011). The Ras/Raf/MEK/ERK pathway is
dysregulated in approximately 30% of all cancers  (Fang and Richardson 2005).
The  activation  of  EGFR  signaling  pathway  results  in  uncontrolled  proliferation  of
colon  cancer  stem  cells  (Feng  et  al.  2012).   The  role  of  EGFR   signaling  has  been
related  with  early  stages  of  colon  carcinogenesis  such  as  microadenoma  formation
(Fichera  et  al.  2007),  and  inhibition  of  EGFR  signaling  is  shown  to  inhibit  polyp
formation (Roberts et al. 2002, Buchanan et al. 2007). Previously, increased levels of
both total and phosphorylated EGFR were seen in Apc-null tumors of ApcMin mice
as  well  as  in  the  intestinal  mucosa,  where  Apc  function  was  reduced  (Moran  et  al.
2004).
2.2.7 Colon cancer and epigenomics
Gene expression and activity can be regulated epigenetically without changing the
DNA sequence of the gene. The major types of epigenetic regulation are DNA
methylation, histone modification and RNA interference.
DNA  methylation  is  a  normal  mechanism  by  which  cells  regulate  gene  activity.  In
DNA  methylation,  methyl  groups  are  added  enzymatically  to  the  5-position  of
cytosine. Cytosine-guanine dinucleotide sequences, called CpGs, are preferably
methylated  by  DNA  methyltransferase.  In  the  mammalian  genome,  most  of  CpGs
located outside of promoter regions are methylated. Unmethylated regions of CpGs
are located in so called CpG islands, where CpGs exist in sequences longer than 200-
500 bases. CpG islands are often located within the promoter region of genes and are
normally  protected  from  methylation.  In  colorectal  cancer,  CpG  islands  within  the
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promoter region are aberrantly hypermethylated (Goel and Boland 2012).
Methylation  of  CpG  islands  suppresses  gene  expression  by  altering  chromatin
structure and hindering transcription factors from accessing the promoter.
Hypermethylation is deteceted in tumor suppressor genes such as, APC, CDKN2A,
MLH1 and CDH1 (Lao and Grady 2011, Goel and Boland 2012). Opposite to the local
hypermethylation  in  promoter  regions,  global  hypomethylation  of  DNA  is  an  early
event in the development of colorectal cancer and may contribute to genomic
instability (Goel and Boland 2012).
Histone modifications and RNA interference also regulate gene expression in human
cancers; however alterations in these mechanisms are less well understood than in
DNA methylation. Dietary factors including folate, polyphenols and isoflavones could
mediate their anti-carcinogenic effect through epigenetic modifications (Supic et al.
2013).
2.2.8 Sterol metabolism in cancer cells
Cancer cells are in high-demand of energy to support rapid cell division. Tumor cells
re-programme their  metabolic  pathways in order to produce increasing amounts of
energy-rich ATP and macromolecules (carbohydrates, proteins, lipids and nucleic
acids)  that  are  needed  for  cell  growth  and  proliferation  (Cairns  et  al.  2011).  The
changes  in  tumor  cell  metabolism  are  caused  by  genetic  mutations  or  continuous
exposure to growth factors (Wellen and Thompson 2010). The metabolic alteration
in  cancer  cells,  the  Warburg  effect,  was  first  described  by  Otto  Warburg  in  1950’s
(Warburg 1956), but the role of metabolic alterations in cellular transformation has
regained more attention in recent years. It now seems evident that there is cross-talk
between  cell  cycle  and  metabolic  regulation  (Aguilar  and  Fajas  2010),  and  that
altered  energy  metabolism  should  be  regarded  as  and  was  recently  added  by
Hanahan and  Weinberg   (Hanahan and  Weinberg  2011)  as  one  of  the  hallmarks  of
cancer.
Pathways that produce lipids are deregulated in cancer cells. These changes affect the
synthesis of membrane lipids (sterols, phosphoglycerides, sphingolipids), lipids in
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energy homeostasis, and lipids involved in cell signaling (Santos and Schulze 2012).
Up-regulation of the mevalonate pathway, the first steps of cholesterol synthesis, has
been associated with cellular transformation (Singh et al. 2003, Dimitroulakos et al.
2006).  Since  cholesterol  is  a  structural  component  of  the  plasma  membrane,  the
demand for cholesterol is increased in dividing cells. However, cholesterol
biosynthesis  pathway  produces  also  mevalonate  and  isoprenoids  that  are  both
needed for cell growth. Isoprenoids are intermediates of the cholesterol synthesis
pathway that are needed for isoprenylation of small GTPases, such as farnesylation of
Ras  and  geranyl-geranylation  of  Rho,  that  activate  their  signaling  inducing  cell
proliferation (Singh et al. 2003).
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2.3 Phytosterols and cancer
2.3.1 Epidemiological studies
In addition to the serum LDL-C decreasing effect, epidemiological studies have
demonstrated  that  increased  intake  of  plant  sterols  is  associated  with  reduced  risk
for several types of cancer e.g. cancer of lung (Mendilaharsu et al. 1998, Schabath et
al.  2005),  breast  (Ronco  et  al.  1999),  and  stomach  (De  Stefani  et  al.  2000).  The
association between plant sterol  intake and colorectal  cancer is  less consistent.  The
Netherlands Cohort Study on Diet and Cancer did not find association between high
intake of  dietary plant sterols  and reduced risk of  colorectal  cancer after  6 years of
monitoring.  The  intake  of  β-sitostanol  was,  however,  positively  associated  with
cancer  of  distal  colon,  and  the  intake  of  stigmsterol  was  positively  associated  with
rectal cancer in men (Normén et al. 2001).
2.3.2 Experimental research: in vitro studies
The effects and mechanisms of plant sterols on cancer processes have been widely
studied in several in vitro studies with several different cell lines. β-sitosterol, the
main  dietary  plant  sterol,  is  the  most  studied  plant  sterol.  β-sitosterol  has  been
reported to inhibit the growth of human colon cancer cells (Awad et al. 1996, Baskar
et al. 2010), prostate cancer cells (von Holtz et al. 1998a, Awad et al. 2000, Ifere et al.
2010),  breast  cancer  cells  (Awad  et  al.  2003b),  and  leukemia  cells  (Moon  et  al.
2008). No effect on cell growth was seen with β-sitosterol or campesterol treatment
in differentiated CaCo2 cells (Awad et al. 2005).
In studies where β-sitosterol was observed to reduce cell growth, β-sitosterol targets
a number of cellular processes. Evidence indicates that β-sitosterol induces apoptosis
in neoplastic cells (von Holtz et al. 1998, Awad et al. 2003a, Awad et al. 2007, Moon
et al.  2008, Ifere et  al.  2010) including human colon cancer cells  (Choi  et  al.  2003,
Baskar  et  al.  2010),  but  also  in  non-neoplastic  cells  (Rubis  et  al.  2008).  The
mechanism  by  which  β-sitosterol  drives  cells  into  apoptosis  seems  to  be  through
down-regulating  the  expression  of  anti-apoptotic  Bcl-2  protein  (Choi  et  al.  2003,
39
Park et al. 2007, Ifere et al. 2010) and up-regulating pro-apoptotic Bax protein (Choi
et al. 2003). Furthermore, β-sitosterol supplementation has been described to
increase  caspase  activities  (Awad  et  al.  2003a,  Park  et  al.  2007)  and  release  of
cytochrome  c  from  the  mitochondria  (Choi  et  al.  2003).  The  activation  of
sphingomyelin  cycle  and  ceramide  production  may  mediate  apoptosis  after  β-
sitosterol treatment  (von Holtz et al. 1998). Additionally, β-sitosterol has been
reported to regulate cell cycle progression in cancer cells by inducing cell cycle arrest
at  the  G2/M  phase  (Awad  et  al.  2001,  Moon  et  al.  2008),  targeting  microtubule
organization (Moon et al. 2008), up-regulating growth-suppressors (Ifere et al.
2010),  and  reducing  DNA  synthesis  (Park  et  al.  2003).  Studies  on  human  breast
cancer cells (MDA-MB-231) have suggested that β-sitosterol and campesterol
suppress metastatic processes (Awad et al. 2001). However, β-sitosterol has been
reported as pro-proliferative in MCF-7 breast cancer cells (Mellanen et al. 1996, Ju et
al. 2004). At the plasma membrane, cholesterol forms lipid-rafts that are essential
for  cell  signaling.  Several  studies  have  demonstrated  that  plant  sterols  and  stanols
are incorporated to cellular membranes by replacing cholesterol (Awad et al. 1996),
which may result in altered membrane properties and receptor function (Mora et al.
1999, Ratnayake et al. 2000, Awad et al. 2007).
Since  cancer  cell  lines  are  originally  derived  from  cancer  tissues,  the  cells  already
possess characteristics of transformed cells. As a result from genetic and metabolic
defects, these cells may exhibit altered response to apoptosis, growth signaling, etc.
The effect of β-sitosterol on cellular functions is usually compared with the effects of
cholesterol supplementation. Whereas cholesterol treatment supports cancer cell
growth,  β-sitosterol  has  mainly  shown  opposite  effects  in  these  studies.  The
cholesterol-treated cells are also reported to grow faster than the vehicle-treated cells
(Ifere et al. 2010). In summary, different cell lines have different cellular responses
when treated with phytosterols. Most of the research has been conducted with β-
sitosterol, therefore the effects of other phytosterols in cancer processes still remain
unknown.
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2.3.3 Experimental research: in vivo studies
The  effect  of  plant  sterols  on  colon  carcinogenesis  has  been  studied  mainly  in
carcinogen-induced animal models such as the MNU (methylnitrosourea) and DMH
(1,2-dimethylhydrazine) rat. Plant sterol supplementation has been shown to inhibit
colon tumorigenesis in some studies with carcinogen-treated rats (Raicht et al. 1980)
(Janezic  and  Rao  1992),  but  also  no  effects  on  colon  cell  proliferation  (Jia  et  al.
2006) or colon tumor formation (Quilliot et al. 2001) have been reported.
Raicht and co-workers showed that dietary β-sitosterol may protect from chemically-
induced colon tumors (Raicht et al. 1980). They fed MNU-treated male Fischer rats
0.2% β-sitosterol in the diet (95% β-sitosterol, 4% campesterol, 1% stigmasterol) for
28 weeks. In the control group 54% of rats developed tumors whereas 33% of rats in
the plant sterol group had colon tumors, and the reduction in tumor-bearing animals
was significant. Similarly, there was significantly less tumors per animal in the plant
sterol group than in the control group. Furthermore, the size of the proliferative
compartment  in  colonic  crypts  was  reduced  in  MNU-rats  fed  0.2%  sitosterol
compared with control MNU-rats (Deschner et al. 1982).
Quilliot and his group (Quilliot et al. 2001) reported that dietary plant sterols had no
effect  on  colon  tumor  formation  in  MNU-treated  female  Wistar  rats.  They
investigated the effect of plant sterols by feeding 24 mg/d of plant sterols (55% β-
sitosterol, 41% campesterol, 4% stigmasterol of total plant sterols) per rat with or
without  saturated  fat  supplement  for  30  weeks.  There  was  no  difference  in  the
number of colon tumors between plant sterol supplemented rats or control rats. The
cholesterol  and  plant  sterol  content  in  the  feces  was  significantly  higher  in  plant
sterol  supplemented  rats.  The  authors  concluded  that  plant  sterols  modified  gut
microflora, which was seen as increased level of feacal coprostanol, a bacterial
metabolite of cholesterol associated with colon carcinogenesis (Peuchant et al. 1987,
Panda et al. 1999).
More recently, Baskar et al. reported that plant sterol feeding reduced the number of
aberrant  crypt  foci  in  male  DMH-treated  rats  (Baskar  et  al.  2010).  β-sitosterol
isolated from A. curassavica, was given to rats at doses of 5, 10, and 20 mg/kg b.w.
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for  16  weeks,  and  the  reduction  in  the  number  of  aberrant  crypt  foci  was  dose-
dependent (Baskar et al. 2010).
All the studies described above have multiple distinctions in their designs which may
explain  the  inconsistency  in  results.  First,  the  amount  and  timing  of  carcinogen  to
rats  was  different.  Likewise  the  dose  and  the  manner  that  plant  sterols  were
supplemented to rats differed. MNU-instillation and plant sterol enriched diet were
introduced to rats concurrently by Raicht et al. (Raicht et al. 1980) and Baskar et al.
(Baskar et al. 2010) , whereas Quilliot and co-workers (Quilliot et al. 2001) gave the
plant sterol enriched diet to rats after the MNU administration. Second, the
composition of diets was different in their fat and plant sterol composition. Third,
gender of animals varied between studies.
Compared to chemically induced colon cancer models, the ApcMin mouse represents
a  model  that  resembles  more  human  colon  cancer  and  shares  similarities  in  the
mechanisms leading to tumor development.  A study conducted by Sang et al. (Sang
et al. 2006) showed that a wheat bran oil fraction containing plant sterols inhibited
intestinal tumor formation in male ApcMin mice. The decrease in tumor number was
significant  only  in  the  proximal  small  intestine.  It  must  be  emphasized  that
conclusions on the effect of plant sterols in ApcMin mice cannot be drawn from their
study, since the investigated fraction contained other bioactive compounds, too. The
effect of plant sterols or plant stanols on colon tumorigenesis has not been studied in
other genetically modified animal models.
The  effect  of  plant  sterols  on  intestinal  cell  proliferation  has  been  reported  also  in
healthy, wild-type animals (Janezic and Rao 1992, Awad et al. 1997b, Jia et al. 2006).
Janezic  and  Rao  (Janezic  and  Rao  1992)  fed  female  C57BL/6J  mice  a  diet
supplemented  with  either  cholic  acid  or  cholic  acid  and  plant  sterols  (60%  β-
sitosterol, 30% campesterol, 5% stigmasterol) at 0.3%, 1.0% or 2.0% of diet for two
weeks.  Cell  proliferation  was  assessed  by  histological  staining.  Whereas  cholic  acid
increased  the  markers  of  cell  proliferation  in  the  colon  epithelium,  dietary  plant
sterols  significantly  decreased  the  level  of  proliferation  markers  to  the  level  of  the
diet without cholic acid supplementation; however, there was no dose-dependent
effect.  Similarly, in the experiment conducted by Awad et al. (Awad et al. 1997b), a
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diet containing 2% of plant sterols and cholic acid reverted the cholic acid induced
cell  proliferation  when  given  to  male  rats  for  22  days.  Jia  et  al.  (Jia  et  al.  2006)
investigated the effect of different plant sterol and stanol analogues on the
proliferation  of  normal  colonic  mucosal  cells.  Male  Syrian  hamsters  were  given
control diet or diet supplemented with either 1% plant sterol, 1% plant stanol, 1.76%
plant sterol esters of fish oil, 0.71% plant stanol esters of ascorbic acid, or 1.4% plant
stanol esters of ascorbic acid for 5 weeks. The authors found a significant decrease in
colon  cell  proliferation  marker  Ki-67  in  animals  fed  the  0.7%  of  plant  stanol
ascorbate  diet  compared  with  control  diet.  No  further  decrease  in  cell  proliferation
was observed with 1.4% of  plant stanol  ascorbate.  Other plant sterol  analogues had
no effect on cell proliferation. The feeding period in these three experiments ranged
from  2  to  5  weeks  which  is  seemingly  short  time  to  generate  changes  in  normal
colonic mucosa in healthy animals.
In summary, the effect of phytosterols has been studied with a wide range of animal
models. Although, plant sterols reduce tumor formation in carcinogen-induced
models and in cholic-acid induced models, some inconsistency exists (Quilliot et al.
2001). In wild-type animals, the results show also inconsisteny, and the experiments
have  been  rather  short  to  detect  colonic  changes  that  usually  develop  over  a  long
period of  time.  So far,  no proper studies on the effect  of  phytosterols  in genetically
modified animals have been reported.
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2.4 The ApcMin mouse
Colon  carcinogenesis  can  be  studied  in  animals  by  either  inducing  tumor
development by chemical carcinogens or using animals with genetic susceptibility/
prediposition to tumor formation. The Min mouse was first described by Moser et al.
(Moser  et  al.  1990).  C57BL/6J  mice  were  exposed  to  ethylnitrosourea,  a  chemical
carcinogen, and at the age of few weeks, a progeny of these mice developed multiple/
dozens of adenomas in the small intestine: the mouse was therefore named the Min
mouse (Min, multiple intestinal adenomas).
The Min phenotype was found to be inheritable by a dominant mutant allele. Later,
the germline mutation was mapped to mouse chromosome 18.  A point mutation in
the Apc allele converts thymine to adenine resulting in a premature stop-codon (Su
et  al.  1992)  and  leading  to  a  truncated  form of  the  Apc  protein.  The  Min  mouse  is
heterozygous for the Apc allele  meaning that  they have one mutated allele  and one
non-mutated, a normal allele. The suppressive function of the normal allele has to be
lost,  too,  before  an  adenoma  starts  to  develop  (LOH,  loss  of  heterozygosity).  Mice
homozygous for the Min mutation die at gestation  (Moser et al. 1995). The ApcMin
mouse develops approximately 30-50 spontaneous adenomas in the small intestine,
while adenomas in the colon are rare (Bilger et al. 1996). Most of the adenomas are
benign and develop in the distal small intestine. ApcMin mice live to approximately
120  days,  and  the  main  cause  of  death  is  severe  anaemia  and/  or  intestinal
obstruction (Moser et al. 1990).
As  already  described,  in  humans  the APC mutation is involved in the hereditary
colon  cancer  syndrome,  FAP,  but  also  in  non-inherited  colon  cancers.  The  murine
Apc gene shares homology with the human APC gene and 90% of amino acids in the
Apc/APC protein are identical (Su et al. 1992). In contrast to humans, ApcMin mice
develop  tumors  mainly  in  the  small  intestine  and  tumors  in  the  colon  are  rare.
Despite of the differences in the phenotype, the ApcMin mouse has been considered
a  suitable  model  to  study  intestinal  carcinogenesis.  This  animal  model  has  been
widely  used  to  study  the  effect  of  pharmaceutical  agents  as  well  as  dietary
compounds on intestinal tumorigenesis. The data from dietary experiments is found
in colon cancer Chemoprevention Database (http://corpet.free.fr/). The pre-
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cancerous  adenomatous  polyps  found  in ApcMin  mice  are  considered  as  a  strong
end-point marker for dietary chemoprevention in animals and humans (Rafter et al.
2004).
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3 AIMS OF THE STUDY
In this  thesis  we used the tumor-prone ApcMin mouse to study the effects  of  plant
sterols and stanols on intestinal tumor formation. The intestine of the ApcMin mouse
is  susceptible  to  tumor  development.  Furthermore,  unlike  in  chemically  induced
colon  cancer  models  (the  MNU  rat)  where  a  wide  range  of  unidentified  mutations
occur, tumorigenesis in ApcMin mice is primarily driven by the mutation in the Apc.
Since APC mutations are common in human spontaneous colon cancers, the ApcMin
mouse  is  a  more  suitable  model  to  study  human  colon  carcinogenesis.  Previous  to
this work no studies on phytosterols in ApcMin mice have been reported. The dietary
intake of plant sterols or stanols from enriched products was assessed among Finnish
men and women, which has not been done earlier in Finland.
The objectives of the present work were:
1)  To study the effect  of  plant sterols  and stanols  from enriched foods on intestinal
tumor development in the Apc mutated intestine.
2) To study the effect of plant stanol and sterol feeding on the composition of sterols
in the faeces and intestinal mucosa.
3)  To  identify  if  cell  signaling  pathways  related  to  cancer  were  affected  after  plant
sterol and stanol feeding.
4)  To  estimate  the  intake  of  plant  sterols  and  stanols  from  enriched  foods  in  the
FINDIET 2007 Survey.
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4 MATERIALS AND METHODS
This section gives a brief overview of study designs and methods that are presented
in more detail in the original publications (I-III).
4.1 Studies I and II: Feeding phytosterols to ApcMin mice
4.1.1 Mice
The  study  protocol  was  approved  by  the  Laboratory  Animal  Ethics  Committee,
University of Helsinki. Male and female C57BL/6J ApcMin (ApcMin/+) mice were bred
at the Laboratory Animal Centre in Viikki, Helsinki, from inbred mice originally
obtained  from  the  Jackson  Laboratory  (Bar  Harbor,  ME,  USA).  Mouse  DNA  was
extracted using the Wizard Genomic DNA Purification Kit  (Promega,  Madison,  WI,
USA) and the Min genotype was determined by a PCR assay described by Dietrich et
al. (Dietrich et al. 1993). The 5-week-old ApcMin mice  were  assigned  into  the
experimental groups by their weight and litter background (I, II). The mice were
housed in plastic cages in humidity- and temperature-controlled facilities with 12-h
light-dark  cycle,  and  food  and  water  was  given ad libitum. During the experiment,
the mice were weighed and monitored weekly. Mice with considerable weight-loss
within one week were sacrificed before the end of experiment. These mice were
excluded  from the  analysis.  In  addition,  one  plant  sterol  female  was  excluded  from
the  data  (II)  for  having  over  170  intestinal  adenomas.  The  total  number  of  mice
included  in  the  data  is  28  in  Study  I  (8  control  male  and  6  control  female  mice;  7
plant stanol male and 7 plant stanol female mice), and 24 in Study II (6 control male
and 7 control female mice; 6 plant sterol male and 5 plant sterol female mice).
4.1.2 Diets and study designs
All experimental diets were semi-synthetic AIN-93G-based  (Reeves et al. 1993) high-
fat diets. The fat content and fat composition of the diets were designed to mimic a
typical Western-type diet. The proportion of saturated, monounsaturated and
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polyunsaturated  fatty  acids  was  approximately  3:2:1.  All  diets  were  similar  with
respect to their energy values from carbohydrate, protein and fat. The protein,
carbohydrate,  fat,  fatty  acid,  cholesterol,  vitamin  and  mineral  content  of  both  diets
were  otherwise  similar  (Analysis  conducted  by  Agrifood  Research  Finland  and
Division  of  Food  Chemistry,  University  of  Helsinki;  Table  1  in  Paper  I).  The
composition of experimental diets in Studies I and II are presented in Tables 1 and 3.
The  sterol  composition  of  diets  (Tables  2  and  4)  was  analyzed  by  the  method
described in the section “Analysis of fecal and mucosal sterols”.
Study I: The  mice  were  fed  either  a  control  diet  or  a  0.8% (w/w)  plant  stanol  diet.
Plant  stanol  was  added  to  the  experimental  diet  in  the  form  of  freeze-dried  plant
stanol ester enriched food products (Benecolâ, Raisio Group, Finland and Benecolâ,
Valio, Finland; Table 1). The food products added to the control diet did not contain
plant  stanol  esters,  but  they  were  purchased  from  the  same  manufacturer  and
therefore  the  content  of  the  product  was  more  likely  to  be  similar  in  other
ingredients.
Study II: The mice were fed either a control  diet  or  a  0.8% (w/w) plant sterol  diet.
Plant sterol was added to the experimental diet in the form of plant sterol ester
enriched margarine (Becel pro.activ® 35% fat, Unilever). Similarly, margarine from
the same manufacturer (Becel® 35% fat, Unilever) was added to the control diet to
maintain  the  fat  composition  of  diets  as  similar  as  possible.  Freeze-dried  food
products  used  in  the  control  diet  in  Study  I  were  added  to  plant  sterol  diet  and
control diet; this was done to make these two studies as similar as possible in the diet
composition.
Studies I and II: Plant  stanol  and  plant  sterol  diets  contained  0.8%  (w/w)  free
phytosterols.  The  intake  of  phytosterols  from  the  0.8%  (w/w)  enriched  diet  was
estimated to be 20 mg per day per mouse. This amount is equivalent to a calculated
daily intake of 5 g in a human when the intake is adjusted to energy consumption.
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Table 1. Composition of diets in Study I.
Ingredient Control diet
g/kg
Plant stanol diet
g/kg
Freeze-dried products 131.51 131.52
Casein 196.7 197.9
Dextrose 413.2 412.5
Butter 131.4 131.0
Sunflower oil 11.7 11.7
Rapeseed oil 54.9 54.7
Mineral mix AIN-93-MX3 41.6 41.6
Vitamin mix AIN-93-VX3 11.8 11.8
L-cystine 3.6 3.6
Choline chloride 3.6 3.6
BHQ 0.014 0.014
1 Freeze-dried products were cream cheese like product (Keiju, Raisio Group),
cheese-like product (Julia 17, Kyrönmaan Juustomestarit Ltd., Isökyrö, Finland),
pasta (Torino, Raisio Group), and butter milk (Valio).
2 Freeze-dried products were cream cheese like product (Benecolâ, Raisio Group),
cheese-like product (Benecolâ,  Valio),  pasta  (Benecolâ, Raisio Group), and butter
milk (Benecolâ, Valio).
3 Composed according to Reeves et al. 1993.
Table 2. Sterol composition of diets in Study I.
Sterol Control diet
mg/ 100 g
Plant stanol diet
mg/ 100 g
Cholesterol 39.2 37.4
Phytosterols1 56.9 832.6
Plant sterols 56.1 68.4
Brassicasterol 4.5 4.9
Campesterol 21.1 29.2
Sitosterol 30.1 33.5
Stigmasterol 0.5 0.9
Plant stanols 0.8 764.2
Campestanol 0.5 206.7
Sitostanol 0.2 557.5
1Total of plant sterols and stanols
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Table 3. Composition of diets in Study II.
Ingredient Control diet
g/ kg
Plant sterol
diet
g/ kg
Freeze-dried products1 131.5 131.5
Casein 175.8 178.6
Dextrose 376.5 372.8
Butter 64.9 65.3
Sunflower oil 4.2 4.2
Rapeseed oil 66.6 67.0
Becel® (35% fat), Unilever 120.0 -
Becel pro.activ® (35% fat), Unilever - 120.0
Mineral mix AIN-93-MX2 41.6 41.6
Vitamin mix AIN-93-VX2 11.8 11.8
L-cystine 3.6 3.6
Choline chloride 3.6 3.6
BHQ 0.014 0.014
1 Freeze-dried products were cream cheese like product (Keiju, Raisio Group),
cheese-like product (Julia 17, Kyrönmaan Juustomestarit Ltd., Isökyrö, Finland),
pasta (Torino, Raisio Group), and butter milk (Valio).
2 Composed according to Reeves et al. 1993.
Table 4. Sterol composition of diets in Study II.
Sterol Control diet
mg/ 100 g
Plant sterol diet
mg/ 100 g
Cholesterol 21.6 22.4
Phytosterols1 75.0 826.5
Plant sterols 73.0 718.2
Avenasterol 3.0 11.7
Brassicasterol 5.4 25.7
Campesterol 25.1 134.5
Sitosterol 38.6 538.0
Stigmasterol 1.0 8.3
Plant stanols 2.0 108.3
Campestanol 0.5 13.7
Sitostanol 1.5 94.6
1Total of plant sterols and stanols
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4.1.3 Tumor scoring and sample collection
After the 9-week feeding experiments, the mice were killed by CO2 asphyxiation. The
small intestine, caecum and colon were removed and opened along the longitudinal
axis,  rinsed  with  ice-cold  saline,  and  put  flat  on  an  objective  glass.  Tumors  were
scored under microscope connected to a camera and a TV screen. The intestinal
tumors were cut out from the tissue, and the histologically normal-appearing mucosa
was scraped off from lamina propria. The tissue samples were snap frozen in liquid
nitrogen and stored at -70oC. Samples for RNA analysis were stored in stabilization
solution (RNAlater, Qiagen) at -20oC. Blood was collected from the abdominal aorta,
centrifuged and the plasma was stored at  -20oC. Fecal samples were collected from
the caecum of each mouse and were stored at -20oC.
4.1.4 Plasma lipids
Plasma triacylglycerol and cholesterol concentrations were analyzed using enzymatic
colorimetric assays by KoneLab 20 analyzer (Thermo Electron Corporation,
Finland), and calibrators and control samples from the manufacturer were used.
4.1.5 Analysis of fecal and mucosal sterols
Study I: The  sterol  composition  was  analyzed  from  faeces  and  the  mucosa  of
proximal small intestine for each mouse by applying a method described by Soupas
et al. (Soupas et al. 2005). Dihydrocholesterol (95%, Sigma, St. Louis, MO, USA) was
added to each sample as an internal standard.  Briefly, ethanol and saturated
potassium hydroxide were added to each sample and the esterified sterols were
hydrolyzed in a shaking incubator for 30 minutes in 85oC. After hydrolyzation, water
and  cyclo-hexane  were  added  to  extract  sterols  into  solvent  phase.  To  obtain  a
detectable concentration of  sterols,  solvent was evaporated from the samples of  the
control mice.
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Study II: Free and esterified sterols were analyzed from faeces and the mucosa of the
proximal small intestine. Dihydrocholesterol (95%, Sigma, St. Louis, MO, USA) was
added to each sample as an internal standard and 5α-cholestane (Sigma, St. Louis,
MO, USA) was added to control the separation of esterified sterols from free sterols
by solid phase extraction (SPE). The sample was first homogenized and incubated in
a mixture of 0.5 M natrium acetate, methanol, and chloroform (1.6:4:2, vol:vol:vol).
The incubation was continued by adding first  chloroform and finally  Milli-Q-water.
The chloroform phase was transferred to a round bottom flask, and chloroform was
evaporated  in  50oC. The lipids were collected from the flask with heptane-
diethylether (9:1, vol:vol). This extract was used to fractionate free and esterified
sterols  with  SiOH-column  (Strata  SI-1  Silica  500  mg;  Phenomenex,  Torrance,  CA,
USA) in a SPE vacuum manifold (Supelco Visiprep DL, Sigma-Aldrich Co.).
Prior to the gas chromatographic analysis, derivatives of sterols were obtained using
pyridine  and  BSTFA:TMCS  (99:1,  vol:vol)  as  silylation  agents  (1:1,  vol:vol).  The
sample  was  injected  into  a  RTX-5  w/Integra  Guard  (crossbond  5%  diphenyl-95%
dimethyl polysiloxane) capillary column (60 m x 0.32 mm i.d., 0.10 µm film; Restek,
Bellefonte, PA, USA) by automated injector of a gas chromatograph equipped with a
flame ionization detector (Agilent 6890N Network GC System, Agilent Technologies,
USA). Sterols were quantified using an internal standard method. Identification was
based on retention times and GC-mass spectrometric analysis. A sample of rapeseed
oil was used to control interassay variation.
4.1.6 Western blot analysis
Sample preparation and Western blot analysis have been described in more detail in
original publications (I, II). Shortly, proteins were isolated from normal-appearing
mucosa of the distal small intestine which represents approximately 40% of total
small intestine. Tissue samples were homogenized in ice-cold buffer with enzyme
inhibitors. A homogenate containing all the cellular proteins was prepared, and
nuclear, cytosolic and membrane proteins were separated by centrifugation and
concentrated using the Amicon Ultra-4 Centrifugal Filter Devices (Millipore,
Bedford,  MA,  USA).  The  protein  content  for  each  sample  was  measured  by  the
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Bradford assay (Protein Assay, Bio Rad, Hercules, CA, USA). The samples were
stored in denaturating buffer in -70oC.
Proteins were separated in sodium dodecyl suplhate (SDS) gels from which they were
transferred to nitrocellulose or polyvinyl membranes using an electric current. After
blocking  the  membrane  against  unspecific  binding  of  primary  antibody,  the
membrane was incubated with primary antibody specified in the original
publications. For detection and quantification, proteins were transferred to an X-ray
film  (Amersham),  scanned  and  analyzed  by  GSA-800  Calibrated  Imaging
Densitometer and Quantity One Program (BioRad Laboratories), or scanned with
Odyssey infrared imager (LI-COR, Inc.,  Nebraska,  USA).  β-Actin and lamin B were
used to control equal loading of protein samples.
4.1.7 RNA isolation and microarray and global gene expression statistics
Total  RNA  was  extracted  from  ileal  mucosa  sample  by  using  the  RNeasy  Mini  kit
(Qiagen). The tissue sample was stored in stabilization solution (RNAlater, Qiagen)
until  RNA  extraction.  Purity  and  integrity  of  RNA  samples  were  verified  by  using
spectrophotometry and agrose gel electrophoresis (Study I) or Bioanalyzer 2100
(v2.6, Agilent Technologies, Inc.)(Study II).  Equal amounts of total RNA was taken
from each mouse to make a pooled sample for each group. In Study II, samples were
pooled by gender.
In microarray experiment, the expression of a large number of genes can be detected
using oligonucleotide probes on a single chip. The hybridization of the fluorescently
labeled target gene (sample RNA) to its probe produces a signal that is then detected
and quantified. In Study I, the pooled samples were analyzed by using the Affymetrix
microarray platform. The labeling, hybridization and scanning were performed at the
Centre  for  Biotechnology,  University  of  Turku,  Finland.  In  Study  II,  Agilent  Whole
Mouse Genome 4x44K microarray assay. The labeling, hybridization and scanning
were  performed  at  the  Biomedicum  Functional  Genomics  Unit,  University  of
Helsinki.
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For the global gene expression data statistics were applied to detect enriched
functional categories or pathways associated with the genes regulated by plant stanol
or plant sterol feeding by using Database for Annotation, Visualization and
Integrated Discovery (DAVID) v6.7 (Huang et al. 2007). This analysis was conducted
to  diminish  the  effect  of  false  positives,  as  only  a  large  body  of  genes  with  similar
functions will show as significant enrichment. More detailed description of analyses
are provided in the original papers (I,II). For all analyses a P <0.05 was considered
statistically significant.
4.1.8 Statistical analyses
In Study I, genders were combined for statistical analysis since plant stanol feeding
affected  both  genders  in  similar  manner.  In  Study  II,  plant  sterols  feeding  affected
adenoma formation and mucosal sterol composition in different manner and
therefore  genders  were  analyzed  separately  for  all  variables.  In  Study  I,  the  non-
parametric Mann-Whitney U-test was used to compare the tumor, sterol and protein
data between the experimental groups. In Study II, the normality of data was tested
using  the  Shapiro-Wilkinson  test,  and  comparisons  within  genders  were  conducted
using the independent-samples t-test.  The Pearson’s  correlation was applied to test
associations between variables. The Spearman’s correlation was applied to test
associations between not normally distributes variables. All comparisons in adenoma
number  and  size,  fecal  and  mucosal  sterols,  and  cellular  proteins  between  groups
were performed were performed using SPSS-PASW 18.0 for Windows software,
(SPSS Inc.). For all analyses a P <0.05 was considered statistically significant.
In Study II, the lasso Poisson regression analysis (Tibshirani 1996) (Friedman et al.
2010) that included all measured variables simultaneously, was conducted to explore
which variables had predictive value for the total adenoma number and the analysis
was performed using glmnet package  in  R.  The  lasso  regression  model  was  used
since  there  were  more  variables  than  observations.  The  number  of  predictors  with
non-zero effects was determined using cross-validation, and the overall significance
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of  the  predictive  model  was  assessed  with  permutation  sampling.  Lasso  regression
analysis was not conducted in Study I, due to the non-normality of parameters.
4.2 Study III: Estimation of phytosterol intake in the FINDIET 2007
Survey
4.2.1 Subjects and methods
The intakes of  phytosterols  were calculated from the data collected by the National
FINDIET 2007 Survey, which was conducted as a part of the National FINRISK 2007
Study at the National Institute for Health and Welfare, THL, in Finland  (Valsta et al.
2010).  The FINDIET 2007 Survey collected data on dietary habits  from 33% of  the
FINRISK 2007 Study participants by 48 h dietary recall carried out by nutritionists
trained for the method. A detailed description on dietary data collection is described
by Reinivuo and co-workers (Reinivuo et al. 2010). The study included 958 men and
1080 women aged 25-74 from five regions in Finland.
Users of phytosterol enriched products were identified from the 48 h dietary recall.
Intakes of phytosterols, cholesterol, energy, and selected nutrients were calculated
based on the 48 h dietary recall with the national food composition database Fineli®
(version 2012) at THL (Reinivuo et al. 2010). Users (n=194) and non-users (n=1844)
of  phytosterol  enriched  food  products  were  compared  with  respect  to  sex,  age,
education, region, cholesterol-lowering medication, and cholesterol-lowering diet.
Mean daily intakes of phytosterols, energy and selected nutrients were compared
between  the  users  and  the  non-users.  The  distribution  of  phytosterol  intake  was
assessed for users of phytosterol enriched products and for users of plant sterol and
plant stanol enriched products separately.
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4.2.2 Statistical analyses
Differences in plant sterol and stanol intakes between men and women were tested
using  analysis  of  variance.  If  the  variances  of  men  and  women  were  unequal,  we
conducted  Welch's  ANOVA.  Mann-Whitney  U-test  for  untransformed  values  was
used if the intakes were non-normal. The relationship between the use of phytosterol
enriched products and the characteristic variables were tested using Fisher’s exact
test. Differences in nutrient intakes between users and non-users of phytosterol
enriched foods were tested using analysis of variance, adjusting for age. The analyses
were conducted also using education as a covariate in the model as well as the use of
cholesterol medication and/or cholesterol lowering diet. The statistical analyses were
performed  using  the  SAS  statistical  package  (SAS  Institute  Inc.,  Cary,  NC,  USA,
version 8.2).
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5 RESULTS
This  section  focuses  on  the  results  of  plant  stanol  and  sterol  feeding  on  intestinal
tumor formation and cell signaling proteins related to tumorigenesis. The results on
Study I are presented genders combined in the original publication since the effect of
plant stanol feeding on adenoma formation was similar in both genders. The effects
of plant sterols and stanols on sterol composition of intestinal mucosa are compared
here  more  closely  by  gender,  which  has  not  been  done  in  a  similar  detail  in  the
original publications.
5.1 Effects of phytosterol feeding on intestinal tumor formation in
ApcMin mice
Generally,  mice  grew  well  in  Studies  I  and  II  and  there  was  no  difference  in  body
weight  gain  between  the  groups  in  either  study.  Both  plant  stanols  (Study  I)  and
plant  sterols  (Study  II)  significantly  increased  the  number  of  intestinal  adenomas,
but not their size (Tables 5 and 6). In Study I, the number of adenomas in the entire
small intestine was higher in the plant stanol mice (mean ± SD; 64.9 ± 22.1) than in
the control mice (40.1 ± 13.9, P=0.002; Fig. 5A and Table 5), and the effect was seen
in  males  (plant  stanol  56.4  ±  20.6  vs.  control  33.5  ±  8.2, P=0.01) and in females
(plant stanol 73.4 ± 21.7 vs. control 48.8 ± 15.7, P=0.054; Fig. 5B). In Study II, plant
sterol feeding increased the total number of intestinal adenomas (plant sterol 43.7 ±
7.9 vs. control 35.6 ± 8.5, P=0.025;  Fig.  5C).  The  total  number  of  intestinal
adenomas was significantly increased in plant sterol females when compared with
control females (46.8 ± 7.0 and 35.0 ± 9.1, respectively, P=0.036; Fig. 5D), whereas
there was no significant difference between plant sterol and control males (41.2 ± 8.2
and 36.3 ± 8.5 respectively, P=0.34; Fig. 5D).
Both plant stanol  and plant sterol  feeding induced tumor formation strongly in the
distal part of the small intestine (distal three fifths; Table 5). Plant stanol enriched
diet  increased  the  number  of  adenomas  in  the  proximal  part  (proximal  two  fifths),
too,  whereas  plant  sterol  diet  had  no  significant  effect  on  adenoma  number  in  the
proximal intestine. Plant stanol and plant sterol feeding had no effect on the size of
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tumors  in  any  part  of  the  small  intestine  (Table  6).  There  was  no  difference  in  the
number  or  size  of  tumors  in  the  colon  between  control  and  plant  stanol  mice  or
control and plant sterol mice in either gender.
Since plant stanol and plant sterol feeding increased the number of intestinal
adenomas, and not the size, phytosterols appear to influence the initiation of
intestinal tumorigenesis rather than tumor growth in this mouse model.
Figure  5.  The  number  of  intestinal  adenomas  in ApcMin  mice  in  Study  I  by  diet
group (A) and by gender (B). The number of intestinal adenomas in Study II by diet
group  (C)  and  by  gender  (D).  In  Study  I,  mice  were  fed  either  a  control  diet  (C=
control  mice,  n=14)  or  a  0.8%  (w/w)  plant  stanol  diet  (PSta=  plant  stanol  mice,
n=14).  In  Study  II,  mice  were  fed  either  control  diet  (C=  control  mice,  n=13)  or  a
0.8% (w/w) plant sterol diet (PSte= plant sterol mice, n=11). After the 9-week
feeding period the adenomas were counted and the size was measured as described
in  the  Materials  and  methods.  Results  are  presented  as  box-plots,  where  the  box
represents the interquartile range and contains 50% of values. The whiskers extend
to the maximum and minimum values. The median is indicated by a line across the
box.
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Table 5. Number of adenomas in different parts of the small intestine of ApcMin mice1.
Study I
Control Plant stanol (PSta) Control males PSta males Control females PSta females
Mice, n 14 14 8 7 6 7
Distal small intestine2
Mean (SD) 32.9 (11.6) 53.8 (18.4)** 28.0 (6.0) 47.3 (16.8)** 39.5 (14.4) 60.3 (18.8)*
Median (min-max) 31 (21-63) 51 (26-86)** 27.5 (21-37) 45 (26-73)** 38 (24-63) 60 (33-86)*
Proximal small
intestine3
Mean (SD) 7.1 (3.8) 11.1 (4.6)* 5.5 (3.3) 9.1 (4.5)* 9.3 (3.5) 13.1 (4.0)
Median (min-max) 6 (2-14) 10.5 (5-17)* 4.5 (2-13) 8 (5-17)* 10 (4-14) 15 (8-17)
Total small intestine
Mean (SD) 40.1 (13.9) 64.9 (22.1)** 33.5 (8.2) 56.4 (20.6)** 48.8 (15.7) 73.4 (21.7)*
Median (min-max) 36 (24-77) 63.5 (34-103)** 31.5 (24-50) 50 (34-90)** 46.5 (35-77) 71 (41-103)*
Study II
Control Plant sterol (PSte) Control males PSte males Control females PSte females
Mice, n 13 11 6 6 7 5
Distal small intestine2
Mean (SD) 28.4 (7.5) 37.5 (6.5)** 28.3 (7.0) 36.2 (6.4) 28.4 (8.4) 39.2 (7.0)*
Median (min-max) 30 (17-39) 36 (26-46)** 28 (18-39) 36 (26-46) 31 (17-39) 44 (31-45)*
Proximal small
intestine3
Mean (SD) 7.2 (2.8) 6.2 (2.8) 8.0 (2.8) 5.0 (2.3) 6.6 (2.8) 7.6 (3.0)
Median (min-max) 7 (4-12) 7 (3-11) 8.5 (4-11) 4.5 (3-8) 6.0 (4-12) 8 (3-11)
Total small intestine
Mean (SD) 35.6 (8.5) 43.7 (7.9)* 36.3 (8.5) 41.2 (8.2) 35.0 (9.1) 46.8 (7.0)*
Median (min-max) 36 (22-49) 43 (29-56)* 35 (24-49) 41 (29 -54) 37 (22-47) 47 (40-56)*
* Different from control, P<0.05; different from control, ** P≤0.01.
1The intestinal adenomas were counted under a light-microscope after the 9-week feeding period.
2The distal three fifths of the small intestine.
3The proximal two fifths of the small intestine.
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Table 6. Size (diameter, mm) of adenomas in different parts of the small intestine of ApcMin mice1.
Study I
Control Plant stanol (PSta) Control males PSta males Control females PSta females
Mice, n 14 14 8 7 6 7
Distal small intestine2, mm
Mean (SD) 1.0 (0.1) 1.1 (0.1) 1.1 (0.1) 1.1 (0.1) 1.0 (0.1) 1.0 (0.2)
Median (min-max) 1.1 (0.8-1.2) 1.1 (0.8-1.2) 1.1 (1.0-1.2) 1.1 (1.0-1.2) 0.9 (0.8-1.3) 1.0 (0.8-1.2)
Proximal small intestine3,
mm
Mean (SD) 1.9 (0.4) 1.7 (0.3) 2.1 (0.4) 1.7 (0.3) 1.7 (0.3) 1.7 (0.2)
Median (min-max) 1.8 (1.5-2.6) 1.6 (1.1-2.2) 2.1 (1.5-2.6) 1.8 (1.1-2.1) 1.6 (1.5-2.1) 1.5 (1.5-2.2)
Total small intestine, mm
Mean (SD) 1.2 (0.1) 1.2 (0.1) 1.2 (0.1) 1.2 (0.04) 1.1 (0.1) 1.1 (0.2)
Median (min-max) 1.2 (1.0-1.3) 1.2 (0.9-1.4) 1.2 (1.1-1.3) 1.2 (1.1-1.2)* 1.1 (1.0-1.3) 1.1 (0.9-1.4)
Study II
Control Plant sterol (PSte) Control males PSte males Control females PSte females
Mice, n 13 11 6 6 7 5
Distal small intestine2, mm
Mean (SD) 1.2 (0.2) 1.2 (0.2) 1.3 (0.1) 1.3 (0.2) 1.1 (0.2) 1.1 (0.1)
Median (min-max) 1.2 (0.8-1.4) 1.2 (1.0-1.6) 1.2 (1.1-1.4) 1.2 (1.1-1.6) 1.1 (0.8-1.3) 1.1 (1.0-1.2)
Proximal small intestine3,
mm
Mean (SD) 1.6 (0.2) 1.5 (0.5) 1.6 (0.1) 1.6 (0.6) 1.7 (0.3) 1.4 (0.3)
Median (min-max) 1.7 (1.3-2.2) 1.4 (1.0-2.7) 1.6 (1.4-1.8) 1.4 (1.1-2.7) 1.7 (1.3-2.2) 1.3 (1.0-1.7)
Total small intestine, mm
Mean (SD) 1.2 (0.2) 1.2 (0.2) 1.3 (0.1) 1.3 (0.2) 1.2 (0.2) 1.1 (0.1)
Median (min-max) 1.3 (0.9-1.4) 1.2 (1.0-1.6) 1.4 (1.1-1.4) 1.3 (1.1-1.6) 1.2 (0.9-1.4) 1.1 (1.0-1.3)
* Different from control, P<0.05.
1 Diameters of intestinal adenomas were counted under a light-microscope after the 9-week feeding period.
2The distal three fifths of the small intestine.
3The proximal two fifths of the small intestine.
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5.2 Effects of phytosterol feeding on plasma lipids in ApcMin mice
No change was seen in plasma lipid concentrations after plant stanol feeding in
Study  I  (Table  7).  In  humans  circulating  cholesterol  is  mainly  transported  in  LDL
lipoproteins but in mice in HDL (Jawień et al. 2004). Therefore phytosterol feeding
does not affect the serum LDL-C levels in mice which has been also observed in other
studies (Calpe-Berdiel et al. 2005). Plasma lipids were not analyzed in Study II.
Table 7. Plasma cholesterol and triacylglycerol concentrations (mean±SD; mmol/l)
in the control and plant stanol group.
Total
cholesterol
HDL LDL TG
Control (n=14) 2.9±0.35 2.4±0.33 0.23±0.12 2.9±0.76
Plant stanol (n=11) 2.8±0.48 2.4±0.51 0.26±0.13 3.0±1.5
5.3 Effects of phytosterol feeding on fecal phytosterols in ApcMin
mice
Both plant stanol and sterol feeding resulted in significantly higher cholesterol, plant
sterol  and  plant  stanol  concentrations  in  the  feces  when  compared  to  controls
(Figure 6; values are presented in Table 2 in Paper I and in Table 1 in Paper II). Fecal
total cholesterol concentration correlated positively with intestinal adenoma number
in Studies I (r=0.570, P<0.01; Fig. 7A) and II (r=0.417, P=0.047; Fig. 7B).
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Figure 6. Fecal sterols (µg/ 100 mg of wet weight) in ApcMin mice after plant stanol
feeding  (Study  I)  by  gender  (A)  and  after  plant  sterol  feeding  (Study  II)  by  gender
(B). Analyses were conducted from caecum content as described in Materials
methods.  Bars  represent  mean  ±  SD.  *  Different  from  control P<0.05. C= control,
PSta= plant stanol, PSte= plant sterol.
Figure 7.  Correlation between total  number of  adenomas in the small  intestine and
fecal  cholesterol  concentration  in  Study  I  (A)  and  Study  II  (B).  C=  control,  PSta=
plant sterol, PSte= plant sterol.
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5.4 Effects of phytosterol feeding on mucosal phytosterols in
ApcMin mice
The sterol profiles of the intestinal mucosa are shown in Figure 8. In study I, sterols
were analyzed as total  sterols  (esterified and free sterols  combined) and in Study II
as  free  and  esterified  sterols.  Plant  stanol  feeding  (Study  I)  increased  the
concentration of sitostanol and campestanol in the intestinal mucosa (P<0.001 for
both; Table 2 in Paper I). The increase in sitostanol concentration was greater than
for campestanol,  and was increased by almost 70 fold in both genders.  In contrast,
concentrations of plant sterols (campesterol, sitosterol) were decreased in plant
stanol fed mice when compared with control mice (P<0.001 for both). The reduction
in  mucosal  campesterol  was  greater  than  for  sitosterol  in  both  genders.  Mucosal
campesterol  and  sitosterol  concentration  was  reduced  by  more  than  half  in  both
genders  after  plant  stanol  feeding  (-51%  in  males,  -61%  in  females),  whereas  the
reduction in mucosal sitosterol was around 40% in both genders.
Plant  sterol  feeding  (Study  II)  increased  the  concentration  of  free  sitosterol  and
campesterol in the intestinal mucosa in both genders (males P≤0.001 for both, and
females P=0.004 and P=0.028, respectively; Table 2 in Paper II). In plant sterol
males the concentration of mucosal free sitosterol was 8-fold greater than in control
males but only 2.8-fold greater in plant sterol females than in control females. Plant
sterol feeding increased the concentrations of esterified sitosterol and campesterol in
males (P=0.027 and P=0.058, respectively) but not in females. The concentration of
free  plant  stanols  was  increased  in  plant  sterol  males  and  females  (by  4.6-fold,
P=0.009, and by 1.7-fold P=0.011, respectively) but no difference was observed in the
concentration of esterified plant stanols in either gender.
In  control  mice  (Studies  I  and  II),  mucosal  phytosterols  were  in  descending  order
campesterol  > sitosterol  > campestanol  > sitostanol.  In plant stanol  mice (Study I),
the  order  was  sitostanol  >  campestanol  >  campesterol  >  sitosterol.  In  plant  sterol
male  mice  (Study  II)  the  order  was  sitosterol  >  campesterol  >  sitostanol  >
campestanol  and  in  plant  sterol  female  mice  (Study  II)  sitosterol @ campesterol  >
sitostanol > campestanol.
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Figure 8. Mucosal sterols (µg/ 100 mg of wet weight) after plant stanol (A) and plant
sterol  (B)  feeding  by  gender  in  the  small  intestine  of ApcMin mice.   Analyses  were
conducted from the intestinal mucosa as described in Materials methods. Bars
represent the mean concentration of total sterols including both free and esterified
sterols. * Different from control P<0.05. C= control, PSta= plant stanol, PSte= plant
sterol.
5.5 Effects of phytosterol feeding on mucosal cholesterol and total
sterols in ApcMin mice
In  Study  I,  the  concentration  of  total  cholesterol  in  the  intestinal  mucosa  was  not
altered after plant stanol feeding in either gender (Fig. 9A). In Study II, plant sterol
fed males had a significantly lower concentration of total and free cholesterol in the
intestinal  mucosa  when compared  with  control  males  (-17%; P=0.008; Fig. 9B and
9C). There was no difference in the free cholesterol between females in Study II. The
concentration of esterified cholesterol in the intestinal mucosa was significantly
decreased in male and female mice after plant sterol feeding when compared with
control mice (-56%; P=0.012 and -38%; P=0.024, respectively; Fig. 9D).
There was no difference in the total concentration of mucosal sterols (total of
cholesterol and plant sterols) between control and phytosterol fed mice in either
gender (Study I: males P=0.25 and females P=0.57;  Study  II:  males P=0.94 and
females P=0.55).  There  was  a  trend  towards  a  higher  concentration  of  total  sterols
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and stanols (total of cholesterol, plant sterols and stanols) in plant stanol males and
females (P=0.083 and P=0.063, respectively). In Study II, no difference was found in
total  mucosal  sterols  and  stanols  between  control  and  plant  sterol  males  (P=0.67)
and females (P=0.49).
Overall, no change was seen in the mucosal total sterol and stanol concentration after
plant  sterol  feeding.  The  accumulation  of  plant  sterols,  sitosterol  in  specific,  in  the
intestinal  mucosa  of  plant  sterol  males  was  accompanied  by  decrease  in  mucosal
cholesterol  concentration  (Study  II).  By  contrast  plant  stanol  feeding  increased  the
total concentration of sterols and stanols in the intestinal mucosa resulting from the
accumulation of plant stanols as demonstrated in Fig. 9.
Figure 9.  Total  cholesterol  concentrations (µg/ 100 mg) in the intestinal  mucosa of
ApcMin  mice  after  plant  stanol  (A)  and  plant  sterol  (B)  feeding.  Concentrations  of
free (C) and esterified cholesterol (D) were analyzed separately from the intestinal
mucosa  in  the  plant  sterol  study  as  described  in  Materials  and  methods.  Bars
represent  mean  ±  SD.  *  Different  from  control P<0.05.  C=  control,  PSta=  plant
stanol, PSte= plant sterol.
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5.6 Effects of phytosterol feeding on the regulation of cholesterol
synthesis in the intestinal mucosa of ApcMin mice
The sterol regulatory element binding proteins (SREBP) act as transcription factors
for genes that up-regulate cholesterol biosynthesis. When cellular free cholesterol
decreases,  the  level  of  nuclear  SREBP-2  increases  (Brown  and  Goldstein  1997).  In
Study I, no difference was detected in the level of active nuclear SREBP-2 between
plant  stanol  and  control  mice  in  either  gender  (Fig.  10A).  In  Study  II,  the  level  of
nuclear  SREBP-2  was  significantly  increased  in  plant  sterol  males  when  compared
with  control  males  (P=0.045;  Fig.  10B).  There  was  no  difference  in  the  level  of
nuclear SREBP-2 between plant sterol and control females. Moreover, phytosterol
feeding did not affect the level of precursor SREBP-2 in Studies I and II.
Figure  10.  Levels  of  nuclear  SREBP-2  (arbitrary  units)  in  the  intestinal  mucosa  of
ApcMin  mice  after  plant  stanol  (A)  and  plant  sterol  (B)  feeding.  Proteins  were
extracted from the intestinal mucosa and fractioned into different cellular
compartments. After separation by SDS gel electrophoresis, the proteins were
detected  by  immunoblotting  (Western  blot)  and  visualized  using  infrared  dye  as
described in Materials and methods. Results are presented as box-plots, where the
box represents the interquartile range and contains 50% of values. The whiskers
extend  to  the  maximum  and  minimum  values.  The  median  is  indicated  by  a  line
across  the  box.  Representative  bands  of  SREBP-2  from  Western  blot  are  shown
below the box plots. *Different from control P<0.05. C= control, PSta= plant stanol,
PSte= plant sterol.
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Global  gene  expression  was  analyzed  by  microarray  assay  using  RNA isolated  from
the histologically normal-appearing mucosa of the distal small intestine. After
enrichment analysis, the cholesterol biosynthesis pathway showed significant
enrichment  for  upregulated  genes  in  the  intestinal  mucosa  of  plant  stanol  mice
(P=1.06E-6;  Fig.  11)  and  in  plant  sterol  females  (P=0.014,  Fig.  11)  but  not  in  plant
sterol males.
Overall,  the  nuclear  SREBP-2  level  was  increased  only  in  plant  sterol  males  with
reduced cholesterol concentration in the intestinal mucosa. In contrast, the genes of
the cholesterol biosynthesis pathway were upregulated in plant stanol mice and plant
sterol  female  mice,  but  not  in  plant  sterol  male  mice.  This  result  is  in  concordance
with the observed effects of plant sterol and stanol on the number of intestinal
adenomas in ApcMin mice.
Figure 11. Cholesterol biosynthesis pathway. A black cross indicates an upregulated
gene in plant stanol mice and a red cross plant sterol female mice when compared
with control mice. The red asterix indicates an upregulated gene in plant sterol male
mice  when  compared  with  control  mice.  (Produced  according  to  the  KEGG
database.)
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5.7 Effects of phytosterol feeding on cell signaling proteins in
ApcMin mice: Wnt and Egfr pathways
Plant stanol feeding increased levels of nuclear β-catenin and cyclin D1, a β-catenin
target (P=0.043 and P=0.065,  respectively;  Table  8;  Fig.  3A  and  B  in  Paper  I).
Furthermore, the level of phospho-Ser675- β-catenin, a transcriptionally active form
of β-catenin (Fang et al. 2007),(Galisteo et al. 1996), was significantly higher in plant
stanol  mice  than  in  the  control  mice  (Fig.  4  in  Paper  I).  In  Study  II,  there  was  no
difference in the level of nuclear β-catenin or cyclin D1 in either gender between
plant sterol and control group (Table 9).
Levels of Egfr, ERK1/2 and Akt were analyzed from whole mucosa lysate. In Study I,
levels of total and phosphorylated (activated) Egfr were significantly higher in the
plant stanol group when compared with the control group (Table 8; Fig. 3C and D in
Paper I). Plant stanol feeding resulted in significantly higher level of phosphorylated
ERK1/2 (p44/42) with no difference in the total level of ERK1/2 (Table 8; Fig. 3E in
Paper I).  The total  level  of  Akt was elevated in the mucosa of  plant stanol  fed mice
(P=0.077), whereas no difference was seen in the level of phosphorylated Akt (Table
8). In Study II, plant sterol feeding had no effect on the levels of Egfr and ERK1/2 in
either gender (Table 9).
Increased protein levels of nuclear β-catenin and cyclin D1 after plant stanol feeding
demonstrate  upregulation  of  the  Wnt  pathway.  Similarly  Egfr  signaling  was
upregulated in plant stanol mice. Activation of Wnt and Egfr pathways are related
with  early  stages  of  tumorigenesis,  and  increased  signaling  of  these  pathways  is
associated with increased cell proliferation, aberrant crypt and adenoma formation
(Bienz  and  Clevers  2000,  Roberts  et  al.  2002,  Näthke  2004,  Fichera  et  al.  2007).
Therefore  the  increased  formation  of  intestinal  adenomas  in  plant  stanol  mice
appears to be caused by upregulation of Wnt and Egfr signaling.
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Table 8. Results from Western blot analysis after plant stanol feeding (Study I)1.
Protein Control
mice
Plant stanol
mice
Statistical
difference,
P-value2
β-Catenin
membrane 2.7 (2.5) 3.8  (2.7) 0.18
cytosol 1.8 (1.7) 2.5 (1.2) 0.081
nucleus 3.7 (2.4) 6.0 (2.7) 0.043
Phospho-Ser675- β-catenin 11.3 (8.3) 21.7 (12.9) 0.027
Cyclin D1, nucleus 4.1 (4.8) 6.9 (5.1) 0.065
Egfr 1.1 (1.5) 3.2 (2.6) 0.031
Phospho-Egfr 0.47 (0.30) 0.72 (0.32) 0.089
ERK1/2 5.0 (0.71) 5.3 (0.81) 0.44
Phospho-ERK1/2 2.2 (1.5) 3.8 (2.5) 0.039
Akt 0.87 (0.63) 1.4 (0.77) 0.077
Phospho-Akt 0.96 (0.72) 1.2 (1.1) 0.49
1 Values represent mean (std. deviation) in arbitrary units
2 Difference between groups was analyzed by non-parametric Mann-Whitney U-test
 * Different from control P<0.05.
Table 9. Results from Western blot analysis after plant sterol feeding (Study II)1
Protein Control
male mice
Plant sterol
male mice
Control
female mice
Plant sterol
female mice
β-Catenin
membrane 2.3 (1.8) 2.7 (1.3) 2.7 (2.0) 4.0 (1.1)
cytosol 0.18 (0.2) 0.16 (0.1) 0.52 (0.4) 0.61 (0.2)
nucleus 1.5 (0.7) 1.3 (0.4) 1.9 (1.3) 2.2 (0.8)
Cyclin D1, nucleus 0.56 (0.2) 0.92 (0.8) 1.8 (1.6) 1.4 (0.8)
Egfr 2.0 (1.1) 1.9 (1.2) 2.3 (1.8) 3.0 (0.7)
Phospho-Egfr 0.86 (0.3) 1.0 (0.5) 0.96 (0.4) 0.89 (0.1)
ERK1/2 5.5 (0.4) 5.7 (0.6) 5.5 (0.5) 5.3 (0.6)
Phospho-ERK1/2 1.1 (0.9) 1.3 (1.0) 0.93 (0.3) 0.77 (0.4)
Caveolin-1, membrane 2.7 (2.5) 6.6 (10.9) 2.1 (1.9) 3.7 (3.7)
ERα 0.82 (0.6) 0.40 (0.2) 0.94 (0.7) 0.91 (0.5)
ERβ 2.4 (0.5) 2.7 (1.4) 2.3 (1.2) 3.2 (0.7)
1 Values represent mean (std. deviation) in arbitrary units, statistical testing between
groups was performed using parametric t-test.
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5.8 Effects of phytosterol feeding on estrogen receptors in the
intestinal mucosa of ApcMin mice
Because  plant  sterol  feeding  in  Study  II  induced  tumor  formation  more  strongly  in
female ApcMin  mice  and  because  Wnt  and  Egfr  pathways  did  not  appear  to  be
involved in the tumorigenesis, we evaluated the level of estrogen receptor (ER) α and
β subtypes  from  the  intestinal  mucosa.  The  activity  of  estrogens  is  mediated  by
estrogen  receptors  α and  β,  and  ERβ is  the  dominant  estrogen  receptor  in  the
intestine  (Foley  et  al.  2000,  Campbell-Thompson  et  al.  2001).  Plant  sterols  bind
weakly  to  ERβ,  and  their  estrogenic  effect  may  be  low  (Gutendorf  and  Westendorf
2001). There was no difference in the level of ERα between the groups in either
gender (Table 9). The level of total ERβ was non-significantly higher in plant sterol
females (Table 9 and Fig. 3 in Paper II). There was a positive correlation between the
total number of tumors and ERβ (r=0.62, P=0.001) and when genders were analyzed
separately the correlation was significant among females (r=0.83, P=0.001; Fig. 12)
but not among males (r=0.347, P=0.269).
Figure 12. The correlation between the number of intestinal tumors and ERβ level.
Results in Fig. C= control, PS/ PSte= plant sterol.
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5.9 Effects of phytosterol feeding on caveolin-1 in the intestinal
mucosa of ApcMin mice
Plant sterols have been reported to regulate caveolin-1 levels in prostate cancer cell
lines  (Ifere  et  al.  2010).  Caveolin-1  is  a  cholesterol  binding  protein  that  forms  lipid
rafts called caveolae at the plasma membrane. Caveolae function as platforms for
proteins and receptors which are regulated by the cholesterol content of the plasma
membrane  (Pike  2005).  Caveolin-1  is  considered  to  act  as  a  tumor  suppressor  by
inhibiting  the  β-catenin  mediated  transcription  of  genes  (Galbiati  et  al.  2000),  and
by  down-regulating  the  activation  of  Egfr  signaling  (Feldman  and  Martinez  2009,
Han  et  al.  2009).  Caveolin-1  levels  were  measured  in  Study  I  and  II  from  total
mucosal  homogenate  and  from  membrane  fraction.  Plant  stanol  and  plant  sterol
feeding had no effect on intestinal caveolin-1 level (Table 9).
5.10 Predictors of increased tumorigenesis in ApcMin mouse after
plant sterol feeding
In Study II, a lasso regression analysis was carried out to detect a model of variables
that  would  best  predict  increased  tumorigenesis.  The  lasso  regression  model  was
used since there were more variables than observations. All measured parameters
including  fecal  and  mucosal  sterols,  and  signaling  proteins  were  included  in  the
model.  Those  variables  that  received  a  coefficient  more  than  0.1  or  less  than  -0.1
were considered strong predictors for increased adenoma number in the model.
Higher levels of ERβ, mucosal sitosterol esters, mucosal free cholesterol, and a lower
level of caveolin-1 were the strongest predictors, and in combination predicted
increased  number  of  tumors  significantly.   The  result  is  in  line  with  the  tumor
suppressive role of caveolin-1. Lasso regression analysis was not conducted in Study I
due to the non-normality of parameters.
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5.11 Intake of phytosterols from enrichment among Finnish men
and women in the FINDIET 2007 Survey
Phytosterol enriched margarines or foods were used by 9.5% (n=194) of the FINDIET
2007 Survey participants, and the use of enriched products was similar among men
(9.2%)  and  women  (9.8%).  The  characteristics  of  users  of  phytosterol  enriched
products are shown in Table 2 in Paper III. The use increased significantly with age
and it was most common among subjects over 64 years of age. The level of education
was significantly associated with the  use  of  phytosterol  enriched  products,  and  the
lowest frequency of users was among people with low education level. Use was more
common among subjects with cholesterol-lowering medication and subjects on
cholesterol-lowering diet when compared with subjects without cholesterol-lowering
medication and diet, respectively (both P<0.0001).
The mean intake of phytosterols among the non-users (plant sterols and stanols from
natural sources) was 363 mg/d for men and 286 mg/d for women. Among the users,
the mean intake of phytosterols was 2.2 g/d for men and 1.6 g/d for women, of which
enrichment  accounted  for  1.9  g/d  (86%)  for  men  and  1.4  g/d  (88%)  for  women
(Table  3  in  Paper  III).  More  than  half  of  the  users  received  less  than  2  g/d  either
plant sterol  or  stanol  from enrichment (Table 10;  Table 4 in Paper III).  Among the
users, 25% of men and 16% of women had an intake of phytosterols more than 3 g/d
(Table 10).
Table 10. Intake of phytosterols among users of phytosterol enriched products based
on 48 h dietary recall1.
All
(n=194)
Men
(n=88)
Women
(n=106)
Mean (g/d) 1.9 2.2 1.6
Median (g/d) 1.6 1.9 1.3
75th percentile (g/d) 2.6 3.1 2.2
90th percentile (g/d) 3.7 4.1 3.3
95th percentile (g/d) 4.1 4.3 3.6
< 2 g/d (%) 62.9 52.3 71.7
2-3 g/d (%) 17.0 22.7 12.3
> 3 g/d (%) 20.1 25.0 16.0
1 The intake of plant sterols and stanols from all dietary sources
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6 DISCUSSION
Phytosterol feeding induces intestinal tumorigenesis in ApcMin
mice
Both plant sterols and stanols (collectively termed as phytosterols) induced intestinal
tumor/ adenoma formation in ApcMin mice. Whereas plant stanol feeding increased
the number of adenomas in both genders, plant sterol had a stronger effect in female
mice.  Both plant sterols  and plant stanols  increased the number but not the size of
intestinal adenomas. The increase in adenoma number indicates that the initiation of
tumor development was enhanced by plant sterol and plant stanol feeding. In other
words, phytosterols affected mechanisms of the early stage in tumor development.
Phytosterols  as  such  have  not  been  studied  earlier  using  the ApcMin mouse, and
studies on plant stanols and intestinal or colon tumorigenesis have not been
reported. Phytosterol feeding to carcinogen treated rodents has been shown to
protect  from  colon  tumor  formation  (Raicht  et  al.  1980),  colon  epithelial  cell
proliferation (Deschner et al. 1982), and aberrant crypt formation (Janezic and Rao
1992).   In MNU-treated male rats,  plant sterols  were shown to reduce colon tumor
formation (Raicht et al. 1980), but not in female MNU-rats (Quilliot et al. 2001). In
healthy rodents, different plant sterol analogues did not influence cell proliferation
(Jia  et  al.  2006).  The  experimental  diets  in  this  thesis  were  enriched  with  0.8%
(w/w)  of  plant  sterols  or  plant  stanols  and  fall  within  the  range  of  earlier  studies
conducted in other animal models.
Plant  stanol  feeding  (Study  I)  up-regulated  Wnt  and  Egfr  signaling  which  are  both
associated with early stages of colon carcinogenesis. In addition, these pathways can
crosstalk and activate one another as well as act in synergy when signaling in concert
(Hu and Li 2010). The activation of Egfr and Wnt signaling after plant stanol feeding
may have resulted in increased cell  proliferation and adenoma formation,  however,
the triggering mechanism behind the activation of these signaling pathways remains
unresolved.  On the other hand,  plant sterol  feeding did not affect  β-catenin or Egfr
levels  in  the  histologically  normal-appearing  intestinal  mucosa.  It  is  possible  that
plant sterols and stanols affect cell signaling differentially in the small intestine.
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Despite the similarity in their structure and efficacy in lowering serum LDL-C, plant
stanols  are  absorbed  less  from  the  intestine  than  plant  sterols  are  (Sanders  et  al.
2000).  Moreover,  plant  stanols  also  decrease  the  absorption  of  plant  sterols
(Hallikainen et al. 2000, Miettinen et al. 2000).
Fecal sterol composition is altered after phytosterol feeding in
ApcMin mice
In Studies I and II, the fecal cholesterol concentration was significantly increased by
plant  sterol  and  stanol  feeding,  and  there  was  a  significant  positive  association
between the number of intestinal adenomas and fecal cholesterol concentration in
both studies. Phytosterols interfere with cholesterol absorption, leading to increased
concentrations of cholesterol and other sterol metabolites in the gut lumen (Rao and
Janezic  1992,  Weststrate  et  al.  1999).  High  intraluminal  cholesterol  concentration
has  been  associated  with  enhanced  cell  proliferation,  aberrant  crypt  and  tumor
formation  in  the  murine  colon  (Kendall  et  al.  1992,  Rao  et  al.  1992).  The
concentration  of  fecal  neutral  sterols  is  reported  to  be  higher  in  individuals  with
colon cancer when compared to control subjects (Peuchant et al. 1987). Furthermore,
cholesterol  is  metabolized  by  intestinal  microbes  to  several  derivatives  that  may  be
carcinogenic (Suzuki et al. 1986, Kaul et al. 1987, Panda et al. 1999).
High intake of phytosterols affects intestinal microbiota and alters the composition
of intraluminal  metabolites (Quilliot  et  al.  2001,  Martínez et  al.  2013).  In the study
conducted with female MNU rats, a mixture of plant sterols induced changes in the
gut microflora that resulted in increased concentration of fecal coprostanol (Quilliot
et al. 2001). Fecal coprostanol is a bacterial metabolite of cholesterol and positively
associated with colon carcinogenesis  (Peuchant et  al.  1987,  Panda et  al.  1999).  In a
recent  study,  a  5%  plant  sterol  diet  induced  changes  in  gut  microbiota  without
affecting fecal concentrations of coprostan-3-one or coprostan-3-ol in male Syrian
hamsters  (Martínez  et  al.  2013).  In  addition,  cholesterol,  but  not  plant  sterols,
inhibited the growth of intestinal bacteria in vitro, and Lactobacillus reuteri was
among the inhibited strains (Martínez et al. 2013). In humans, plant sterol intake of
8.6 g/d for 28 days reduced fecal lactic acid concentration and lactobacilli content
(Ayesh et al. 1999). Changes in the intestinal microflora could potentially contribute
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to intestinal tumorigenesis (Vipperla and O’Keefe 2012), however this thesis does not
provide data on the effect of phytosterol feeding on intestinal microbes, since it was
not in the scope of this work.
Although phytosterols increase the amount of biliary cholesterol excreted into
intestinal lumen, fecal bile acid excretion has been shown to decrease (Uchida et al.
1984, Martínez et al. 2013) or remain unaffected (Raicht et al. 1980, Weststrate et al.
1999,  Trautwein  et  al.  2002,  Calpe-Berdiel  et  al.  2005)  after  phytosterol  ingestion.
Therefore  fecal  bile  acids  as  an  initiating  factor  in  intestinal  tumorigenesis  after
phytosterol feeding seem unlikely.
Taken together, plant sterol and plant stanol feeding resulted in increased
concentrations of cholesterol and phytosterols in the feces of ApcMin  mice,  which
may have caused unbeneficial alterations in the luminal environment. Increased fecal
cholesterol concentration does not, however, explain the gender differences in tumor
formation after plant sterol feeding.
Phytosterol feeding changes the profile of phytosterols in the
intestinal mucosa of ApcMin mice
This thesis  shows that  a  high intake of  plant sterols  (Study II)  increased both plant
sterol and plant stanol concentrations in the intestinal mucosa. In contrast, plant
stanol  feeding  (Study  I)  resulted  in  increased  concentrations  of  mucosal  plant
stanols, whereas concentrations of mucosal plant sterols were lower than in control
mice. Even though sitosterol is the major natural plant sterol in the diet, campesterol
is absorbed more efficiently than sitosterol, and campesterol is the predominant
phytosterol in tissues (McIntyre et al. 1971, Sanders et al. 2000, Igel  et  al.  2003).
This was observed in the sterol composition of intestinal mucosa in the control mice,
but when plant stanol (Study I) and plant sterol (Study II) was fed to mice sitostanol
and  sitosterol  became  the  predominant  phytosterol  in  the  intestinal  mucosa,
respectively.
75
In  Study  II,  genders  responded  in  different  manner  to  phytosterol  diet,  which  was
observed as differences in intestinal sterol composition. Plant sterol males (Study II)
had almost 2-fold higher concentration of sitosterol in the intestinal mucosa than
plant sterol females. Indeed, gender has been found to affect expression and
regulation of  genes involved in lipid and sterol  metabolism (Yang et  al.  2006).  The
absorption  of  cholesterol  and  phytosterols  is  more  efficient  in  female  than  in  male
mice  (Turley  et  al.  1998,  Sanders  et  al.  2000),  and  the  effect  of  gender  has  been
estimated to account for 20% of the variation in plasma plant sterol concentrations
(Chan  et  al.  2006).  For  comparison,  the  impact  of  ABCG5/8  phenotype  has  been
estimated to explain 8% of the variation (Chan et al. 2006).
To summarize, phytosterol feeding changed sterol composition of intestinal mucosa
by increasing total phytosterol concentrations and altering the phytosterol profile of
intestinal mucosa. Plant stanols reduced the uptake of plant sterols by enterocytes. In
addition, genders responded differentially to high intake of plant sterols.
Plant sterol and stanol feeding affect mucosal cholesterol
concentration in a different manner in the intestine of ApcMin mice
In Study I, plant stanol feeding did not affect the concentration of cholesterol in the
intestinal  mucosa  in  either  gender.  By  contrast,  plant  sterol  feeding  (Study  II)
resulted  in  lower  concentrations  of  free  and  total  cholesterol  in  males,  whereas  the
concentrations were unaffected in females. It would be expected that cholesterol
concentration  in  the  mucosa  is  tightly  regulated;  however,  the  results  indicate  that
mucosal cholesterol homeostasis was disturbed in males after plant sterol feeding
(Study  II).  Male  and  female  rodents  differ  in  their  sterol  metabolism  as  shown  by
Turley and co-workers (Turley et al. 1998).
Although plant sterol males had lower concentration of cholesterol, they
accumulated more plant sterols in the intestinal mucosa than females. In fact, the
concentration of total sterols (cholesterol, sitosterol, campesterol, sitostanol and
campestanol) in the mucosa was similar between males and females in Study II. This
suggests that a high concentration of sitosterol interferes with cholesterol
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homeostasis in tissues as also implicated by Yang and co-workers (Yang et al. 2004).
Plant stanol feeding (Study I), on the other hand, did not affect mucosal cholesterol
concentrations since it decreased mucosal plant sterol concentrations equally in both
genders.
In Study II, plant sterol feeding reduced the concentration of esterified cholesterol in
both  genders.  The  finding  supports  earlier  evidence  that  plant  sterols  inhibit  the
acyl-CoA:cholesterol acyltransferase enzyme (ACAT) (Field and Mathur 1983) that
esterifies  cholesterol  before  it  can  be  packed  into  chylomicrons  and  exported  from
the enterocyte. The reduction of cholesterol esterification may partially explain
reduced cholesterol absorption after phytosterol feeding.
Effects of phytosterols on cholesterol synthesis in the intestinal
mucosa of ApcMin mice
The pathway analyses on the microarray data show that plant sterol  feeding (Study
II) resulted in significant enrichment of upregulated genes involved in cholesterol
synthesis  only  in  females  but  not  in  males.  Unfortunately,  samples  from  both
genders were pooled for analysis in the plant stanol study (Study I), and differences
in gene regulation between genders were not possible to determine after plant stanol
feeding. The results from the pathway analyses suggest that reduced cholesterol
absorption stimulated a compensatory cholesterol synthesis in enterocytes in plant
stanol  mice  (Study  I)  and  plant  sterol  females  (Study  II),  since  no  change  was
detected in the mucosal cholesterol concentration in these mice. When the
concentration of intracellular free cholesterol is low, SREBP-controlled transcription
of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), the key enzyme regulating
cholesterol biosynthesis, and LDL-receptor, is increased. As a result, cholesterol
synthesis and cholesterol uptake are increased. In the multistep process of
cholesterol synthesis, 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) is converted to
mevalonate  by  HMGCR,  and  mevalonate  is  then  used  to  produce  isoprenoids  and
cholesterol.
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As expected, the decreased concentration in the mucosal free cholesterol of plant
sterol  males  (Study  II)  was  accompanied  by  increased  levels  of  nuclear  SREBP-2.
Notwithstanding,  the  cholesterol  biosynthesis  pathway  was  not  enriched  for
upregulated  genes  in  plant  sterol  males.  In  this  thesis,  nuclear  SREBP-2  was
increased only when mucosal cholesterol was reduced as seen for plant sterol males,
whereas no changes were seen in nuclear SREBP-2 level when genes of the
cholesterol synthesis were upregulated, as observed in plant stanol mice (Study I)
and plant sterol females (Study II). One explanation for this could be that the genes
of cholesterol biosynthesis were upregulated due to mitogenic signaling instead of a
compensatory mechanism to regulate cellular cholesterol balance. In proliferating
cells, cholesterol synthesis appears to be up-regulated by nuclear SREBP-1 after
activation  of  protein  kinase  B  (PKB/Akt)   (Porstmann  et  al.  2005).  Like  SREBP-2,
SREBP-1 is  a  transcription factor that  regulates the expression of  enzymes involved
in lipid and cholesterol biosynthesis (Osborne 2000). The up-regulated cholesterol
biosynthesis  in  plant  stanol  mice  (Study  I)  and  plant  sterol  females  (Study  II)  may
therefore be a secondary response due to proliferative signaling that does not involve
SREBP-2. In addition, the synthesis of SREBP-2 precursor may be under regulation,
too   (Kim,  Takahashi,  and  Ezaki  1999,  Field  et  al.  2001).  Harding  and  co-workers
(Harding  et  al.  2010)  demonstrated  that  plant  sterol  feeding  to  hamsters  increased
concentrations of hepatic plant sterols and reduced the hepatic free cholesterol
concentration. Since hepatic cholesterol synthesis and inactive SREBP-2 were
increased without an increase in active nuclear SREBP-2, they speculated that plant
sterols downregulated the conversion of SREBP-2 into its active form. Similarly, it is
possible, that conversion of the SREBP-2 precursor into its mature form was affected
after phytosterol feeding although genes of the cholesterol synthesis were
upregulated.
Upregulated cholesterol biosynthesis and increased production of cholesterol
intermediates, such as mevalonate and isoprenoids, has been associated with
increased cell proliferation (Singh  et  al.  2003, Dimitroulakos  et  al.  2006),  and
inhibitors of  the mevalonate pathway may act  as antitumor agents (Thurnher et  al.
2012). Patients with hypercholesterolemia are often treated with statins that inhibit
the HMGCR activity. A meta-analysis of twenty case-control studies found a
significant association between statin usage and reduced risk of colon cancer (Taylor
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et al. 2008). Later, a meta-analysis combining both clinical trials and observational
studies concluded that statin usage was associated with only a modest  reduction in
CRC  (Bardou  et  al.  2010),  however  the  duration  of  clinical  trials  was  too  short  to
assess CRC incidence. Moreover, atorvastatin (Swamy et al. 2006) and pitavastatin
(Teraoka et al. 2011) reduced intestinal polyp formation in the ApcMin mouse.
Statins inhibit  the conversion of  HMG-CoA to mevalonate and reduce the synthesis
of  the  downstream  products,  such  as  farnesyl  pyrophosphate  (FPP)  and
geranylgeranyl pyrophosphate (GPP). A higher FPP synthase activity is found in
human  colorectal  cancer  samples  when  compared  to  normal  surrounding  mucosa
and it is shown to regulate cell proliferation  (Notarnicola et al. 2004). In this thesis,
the expression of enzymes producing FPP and GPP was upregulated in the intestinal
mucosa  of  plant  stanol  fed  mice  (Study  I).  FPP  and  GPP  are  post-translational
modifiers of several proteins including Ras, Rho, Rab and lamin B (Dimitroulakos et
al. 2006, Guruswamy and Rao 2008). These intermediates of the sterol biosynthesis
could  modify  and  activate  Ras,  which  in  turn  activates  EGFR  and  its  downstream
effectors (Dimitroulakos et al. 2006).
Whether increased Egfr activity in plant stanol fed ApcMin  mice  (Study  I)  was  a
result of an increased synthesis of cholesterol and modifiers that activate Ras, is not
certain.  More research is  needed to address the effect  of  plant stanols  in cancer.  So
far, mechanistical studies on the effect of plant stanols using cancer cells are lacking.
Effects of phytosterols on cell signaling pathways in ApcMin mice
This  thesis  demonstrates  that  plant  stanol  feeding  (Study  I)  upregulated  Wnt  and
Egfr signaling, which was not seen after plant sterol feeding (Study II). It is possible
that the small number of animals in Study II may not allow detecting differences in
signaling proteins between the plant sterol and the control group. However, it is very
probable that plant sterols and plant stanols affect cell signaling differentially within
enterocytes.  In  fact,  plant  sterol  and  plant  stanol  diets  changed  mucosal  sterol
composition in completely different manner as discussed earlier. Therefore, it can be
assumed that although very similar in their molecular structure and LDL-C lowering
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efficacy, plant sterols and stanols may diverge in other properties. Even specific plant
sterols, e.g. sitosterol and stigmasterol, differ in their physiological responses (Awad
et al. 2003a, Yang et al. 2004, Sabeva et al. 2011).
After all, plant sterols seem to affect other cellular targets in the ApcMin mouse than
plant stanols do. Plant sterols could contribute to changes in signal transduction by
replacing cholesterol from the plasma membrane (Mora et al. 1999, Ratnayake et al.
2000,  Awad  et  al.  2007).  Plant  sterols  have  been  found  to  upregulate  the  gene
expression of caveolin-1 (Ifere et al. 2010), which is a cholesterol binding protein that
forms  lipid  rafts  called  caveolae  at  the  plasma  membrane.  Caveolae  function  as
platforms for proteins and receptors which are regulated by the cholesterol  content
of  the  plasma membrane.  Caveolin-1  is  considered  to  act  as  a  tumor  suppressor  by
inhibiting  the  β-catenin  mediated  transcription  of  genes  (Galbiati  et  al.  2000),  and
by  down-regulating  the  activation  of  Egfr  signaling  (Feldman  and  Martinez  2009,
Han et al. 2009). In Study II, where plant sterol was fed to mice, low caveolin-1 levels
when  combined  with  increased  concentrations  of  mucosal  free  cholesterol  and
esterified sitosterol, and ERβ content, was associated with increased number of
intestinal adenomas.
The lasso regression analysis (Study II) proposed a higher ERβ level to be among the
predictors of increased adenoma number. Plant sterols themselves bind to ERβ with
low affinity, although their estrogenic effect seems to be weaker than estrogens
(Gutendorf  and  Westendorf  2001).  In  the  colonic  epithelium,  ERβ is  the
predominant estrogen receptor (Foley et al. 2000, Campbell-Thompson et al. 2001).
Plant sterols may disturb estrogen metabolism by competing of binding to estrogen
receptors α and β with estrogens (Newill et al. 2007).
Plant sterols have been reported to accumulate in organs that are involved in steroid
biosynthesis  such  as  the  adrenal  gland  and  ovaries  (Sanders  et  al.  2000).  Plant
sterols  could  disturb  the  synthesis  of  female  sex  hormones,  and  plant  sterol
supplementation has been reported to reduce serum progesterone and estrogen
levels  in humans and in animals (Ayesh et  al.  1999,  Nieminen et  al.  2003,  Ju et  al.
2004).  Epidemiological  and  clinical  studies  suggest  that  estrogens  and  progestin,  a
synthetic progestogen, could protect against colon cancer development  (Grodstein et
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al.  1999,  Rossouw  et  al.  2002,  Lin  et  al.  2012). ApcMin females have lower
progestogen levels compared to wildtype female mice, suggesting that sex hormone
synthesis is disturbed in ApcMin females at  the baseline (Cleveland et  al.  2009).  It
could be that  plant sterols  further disturbed estrogen and/or progestogen signaling
in the small intestine or reduced hormone synthesis in ovaries of ApcMin females.
ERβ deficiency is often associated with increased intestinal tumorigenesis, (Cho et al.
2007, Giroux et al. 2008); however, the positive correlation between tumor number
and ERβ level among females (Study II) could be explained by the findings reported
also for ovariectomized mice (Weyant et al. 2001). Weyant and coworkers (Weyant et
al. 2001) saw that the number of intestinal tumors was increased in ovariectomized
ApcMin  mice,  and  this  loss  of  endogenous  estrogen  production  upregulated  the
expression  of  ERβ (Weyant  et  al.  2001).  If  plant  sterol  feeding  disturbed  estrogen
signaling,  a  compensatory  mechanism  due  to  reduced  estrogen  signaling  could
explain the non-significant increase in ERβ level in plant sterol females.
Plant stanols, on the other hand, are absorbed from the intestine less efficiently than
plant sterols, and their circulating levels are low. The accumulation of plant stanols
in tissues such as ovaries is therefore low or even non-existent, and it is unlikely that
plant stanols affect the hormone synthesis in the ovaries. This may in part define the
different mechanisms behind plant sterol and plant stanol induced tumorigenesis in
ApcMin mice, and why genders were affected in a different manner in the feeding
studies.
Other plausible mechanisms behind intestinal tumorigenesis in
ApcMin mice after phytosterol feeding
It  has  been  suggested  that  in  addition  to  targeting  plasma membrane,  phytosterols
could direct at mitochondria (Rubis et al. 2008, Danesi et al. 2011, Lizard 2011). In
vitro experiments  have  consistently  shown  that  plant  sterols  induce  apoptosis  by
activating pro-apoptotic  proteins (von Holtz  et  al.  1998,  Awad et  al.  2003a,  Choi  et
al.  2003).  Since  mitochondria  are  essential  to  energy  metabolism  and  in  the
regulation of apoptosis, the indication that phytosterols could alter the function of
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these cell organs maybe important, especially in carcinogenesis. As described already
in the literature review, the energy metabolism is altered in cancer cells. The fact that
phytosterols could affect mitochondria raises a concern if they could disturb energy
metabolism  in  cells  by  affecting  mitochondrial  function.  As  a  matter  of  fact,  a
mixture of phytosterols was found to reduce the metabolic activity of non-neoplastic
rat  cardiomyocytes  when  using  an  assay  dependent  on  mitochondrial  reductase
activity  (Danesi  et  al.  2011).  Similarly,  the  metabolic  rate  and  cell  growth  was
reduced in normal human endothelial cells treated with β-sitosterol in vitro (Rubis et
al. 2008). Sitosterol has been found to inhibit the mitochondrial CYP27 enzyme that
converts cholesterol to 27-OH-cholesterol, an oxysterol ligand that activates LXR
(Brauner et al. 2012).
The oxidation products of phytosterols could be potentially toxic to cells (Adcox et al.
2001,  Newill  et  al.  2007).  The  epoxy-β-sitosterol  was  found  less  cytotoxic  than  its
parent compound, β-sitosterol, when delivered to cells as a readily-formed oxidized
phytosterol (Newill et al. 2007). If phytosterols were oxidized within cells, their
oxides could be more harmful than food-derived oxy-phytosterols since they could
generate free radical reactive oxygen species inside the cells. However, phytosterol
oxides  are produced mainly during storage rather than metabolically in vivo (Newill
et al. 2007).
Intake of phytosterols from enriched food products among Finns
Phytosterol  intakes  from natural  sources  and  enriched  foods  were  evaluated  in  the
Finnish  population  based  on  the  national  FINDIET  2007  Survey  (Study  III).  The
intake of phytosterols from natural sources was 363 mg/d for men and 286 mg/d for
women and from enrichment 2.2 g/d for men and 1.6 g/d for women.
Currently,  producers  of  phytosterol  enriched  foods  are  advising  the  customer  to
consume 2  g/d  of  plant  sterols  or  stanols  in  order  to  reach  the  beneficial  effect  on
serum  LDL  cholesterol.  The  majority  of  Finnish  men  and  women  who  used
phytosterol  enriched  food  items  did  not  reach  the  2  g  advised  daily  intake  of
phytosterols.  On  the  contrary,  20%  of  people  that  consumed  enriched  foods  had
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mean intakes above the recommended 3 grams. Although the intake values may have
some measurement error due to the 48 h dietary recall method, similar intake levels
for  phytosterol  from enrichment  have  been  reported  for  Belgian  (Sioen  et  al.  2011)
and  Irish  population  (Hearty  et  al.  2009).  In  the  Irish  study,  23%  of  people  had
intake greater than 3 g/d and 58% of users had consumed phytosterol enriched foods
more than one year (Hearty et al. 2009).
The use of phytosterol enriched products is common among those with increased risk
for  CHD.  In  the  national  FINRISK  2002  Study  almost  80%  of  those  who  used
phytosterol enriched foods reported having high or elevated blood cholesterol level
(de  Jong  et  al.  2004).   In  contrast,  around 20% of  Finnish  users  of  enriched  foods
were not aware of their blood cholesterol level (de Jong et al. 2004). Similar results
were reported for Irish population consuming phytosterol enriched products and
over 35% of users had no diagnosis of a medical condition (Hearty et al. 2009). Over
half of those using enriched products reported advertising to have introduced
enriched  products  in  their  diet  whereas  a  doctor  or  a  dietitian  had  introduced
enriched products to less than 20% of subjects (Hearty et al. 2009). If the decision to
use  enriched  products  is  based  on  advertising  the  information  on  the  use  of  these
products is mainly based on product labels.
The  European  Commission  requires  the  producers  to  label  plant  sterol  and  plant
stanol  enriched  products  with  necessary  information  concerning  the  target  group
and  intake  levels  of  plant  sterols  and  stanols  from  enrichment  (Regulation  EC  No
608/2004).  According  to  post-launch  monitoring  studies  it  seems  that  the  label
information  does  not  reach  the  customer.  In  a  study  conducted  in  Belgium,  21% of
pre-school children aged between 2.5 and 7 years consumed phytosterol enriched
foods,  and  the  mean plant  sterol  intake  was  0.7  g/d  and  the  highest  intake  2.1  g/d
(Sioen et al. 2011). Phytosterol enriched products are not recommended for children
under 5 years of  age (Regulation EC No 608/2004);  however children living in the
same household with parents who consume phytosterol enriched bread spreads are
more likely to use the same enriched spreads.
The long-term effects of phytosterols from enrichment at high intake have not been
studied in humans. So far, only one epidemiological study on phytosterol intake and
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CRC has been published concluding that a high intake of phytosterols did not reduce
CRC risk (Normén et al. 2001). In fact, there were positive associations between the
intake  of  β-sitostanol  and  risk  of  distal  colon  cancer  and  the  intake  of  campesterol
and  stigmasterol  and  risk  of  rectal  cancer  for  men.  In  that  study,  the  dietary
phytosterols  originated from natural  sources and the intake of  plant sterols  even in
the highest percentile was few hundred milligrams (Normén et al. 2001). When the
intake of phytosterols from natural dietary sources is high, intakes of other bioactive
dietary  factors,  such  as  vitamins,  minerals,  antioxidants  and  dietary  fibre,  is  high,
too. In contrast, when phytosterols originate from enriched sources, a high intake of
other health promoting compounds is not guaranteed.
The accumulation of phytosterols in serum of sitosterolemic subjects with a mutation
in  ABCG5/8  transporters  has  raised  the  question  whether  phytosterols  could  be
potentially atherogenic (Sudhop and von Bergmann 2004). In animals without a
genetic defect in sterol transporters, plant sterols have been observed to accumulate
in  several  organs  and  tissues  (Sanders  et  al.  2000,  Vanmierlo  et  al.  2012).  In
humans,  the  customary  (long-term)  use  of  plant  sterol  and  plant  stanol  enriched
margarine  was  shown to  increase  serum phytosterol  concentrations  (Fransen  et  al.
2007). The impact of increased serum phytosterol concentrations and accumulation
of phytosterols in human tissues is yet to be defined.
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SUMMARY AND CONCLUSIONS
Phytosterols  are added to functional  foods for their  blood LDL lowering effect.  The
customary use of  phytosterol  enriched foods appears to be a cost-effective and easy
way to treat people with high or elevated serum cholesterol levels. Whereas the daily
intake of phytosterols from natural sources varies between 150-400 mg (Katan et al.
2003),  the  intake  can  reach  several  grams  when  enriched  foods  are  consumed
(Hearty et al. 2009, Sioen et al. 2011). The long-term effects of phytosterols at high
intakes have not been thoroughly studied in humans.
The effects  of  plant sterols  and plant stanols  were examined in the ApcMin mouse,
which  is  a  widely  used  model  to  study  the  impact  of  diet  on  intestinal  tumor
development.  This  thesis  shows  that  plant  sterols  and  stanols  regulate  several
signaling pathways in the small intestine of ApcMin mice. Plant stanol feeding
increased the number of intestinal tumors, affected sterol metabolism in the mucosa
by increasing plant stanol concentrations and decreasing plant sterol concentrations,
upregulated genes of the mevalonate (cholesterol synthesis) pathway and increased
Wnt and Egfr signaling in the ApcMin mouse. On the other hand, plant sterol feeding
increased the number of intestinal tumors more pronouncedly in female mice,
affected sterol metabolism in the mucosa by decreasing cholesterol concentration in
male mice, and increasing plant sterol and stanol concentrations in the intestinal
mucosa in both genders, and upregulated genes of the mevalonate pathway in female
ApcMin mice.
Prior to this thesis no studies on plant stanols and intestinal/ colon carcinogenesis
have been reported. In addition, phytosterols as such have not been studied using the
ApcMin  mouse.  The  mutation  in  the  human APC is  involved  in  more  than  half  of
spontaneous colon tumors, and the rate of APC mutations in the colon increases later
in  life  (Luebeck  and  Moolgavkar  2002).  At  the  same  period  of  life  the  use  of
phytosterol enriched products often begins. Therefore the ApcMin mouse represents
a feasible model to study the effects of phytosterols on intestinal tumor formation.
Although phytosterols  are  poorly  absorbed  and  their  circulating  levels  are  low,  it  is
now evident that these compounds are taken up by enterocytes where they regualte
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cell signaling and gene expression. Several hypotheses can be made on the increased
initiation  of  tumorigenesis  after  phytosterol  feeding.  However,  based  on  the  data
presented  in  this  thesis,  conclusions  on  the  unequivocal  mechanism  behind  the
accelerated initiation cannot be made.
Phytosterol enriched food products are targeted to the customer for treating serum
LDL-C levels, but instead of being considered as pharmaceuticals these products are
termed  as  functional  foods.  Although  the  European  Commission  requires  the
producers  to  label  plant  sterol  and  plant  stanol  enriched  products  with  necessary
information concerning the target group and intake levels of plant sterols and stanols
from  enrichment  (Regulation  EC  No  608/2004),  it  appears  that  consumers  follow
the  advises  poorly.  Among  the  users  of  phytosterol  endriched  products,  there  is  a
subgroup of consumers whose phytosterol intake from enrichment clearly exceeds
the  advised  intake  of  2  g/d  stated  on  the  product  label.  On  the  other  hand,  the
majority of people using phytosterol enriched foods do not achieve the advised
intake.  Since phytosterol  enriched food products are freely available on the market,
consumer guidance should be developed until more research has been conducted on
the long-term effects of phytosterols at high intake levels.
The  intake  of  plant  sterols  and  plant  stanols  in  the  feeding  studies  with  mice  was
equivalent to approximately 5 g/d in men when adjusted for energy consumption. As
confirmed  by  this  thesis,  high  intake  levels  are  easily  achieved  by  humans  when
enriched food items are consumed. The long-term effects of phytosterol consumption
at high intake have not been evaluated in humans.
This thesis shows that phytosterols clearly influence sterol metabolism in the
intestine, and accelerate the formation of intestinal tumors in a tumor-prone mouse
model. In addition, plausible mechanisms behind the enhanced tumor development
are demonstrated. The present results warrant for future research aimed to
investigate the effects of phytosterols on intestinal health in human.
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